Obstetrics, gynecology and reproductive medicine guidelines

Tuberculosis

Guidelines, reviews, statements, recommendations, standards

 

Latent tuberculosis

• Asia
  • Respirology
    • Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective [2013]
• Australia
  • Australian Journal of General Practice
    • Latent tuberculosis in the general practice context [2020]
  • Department of Health Australia
    • Position statement on interferon-gamma release assays for the detection of latent tuberculosis infection [2018]
    • National position statement for the management of latent tuberculosis infection [2017]
    • Treatment of latent tuberculosis in migrants to Victoria [2015]
    • Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention [2015]
  • Queensland Clinical Guidelines
    • Management of Latent Tuberculosis in Children up to 16 years [2016]
    • Management of Latent Tuberculosis in Adults [2016]
• Australia, New Zealand
  • Tuberculosis Research and Treatment
    • Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice [2010]
• Canada
  • BMC Public Health
    • Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries [2018]
  • BMJ Open
    • Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study [2017]
  • Canadian Agency for Drugs and Technologies in Health
    • Strategies for the Management of Latent or Previously Treated Tuberculosis: Clinical Effectiveness, Cost-Effectiveness, and Guidelines [2018]
  • Public Health Agency of Canada
    • Latent tuberculosis infection: An overview [2017]
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Treatment of Latent Tuberculosis infection [2014]
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Diagnosis of Latent Tuberculosis infection [2014]
    • Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection - 2010 update [2010]
• China
  • International Journal of Infectious Diseases
    • Management of Latent Tuberculosis Infection in China: Exploring solutions suitable for high-burden countries [2020]
  • PLoS ONE
    • Latent Tuberculosis Infection and Occupational Protection among Health Care Workers in Two Types of Public Hospitals in China [2014]
• Colombia
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
    • Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis [2018]
• Europe
  • European Centre for Disease Prevention and Control
    • Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management [2018]
    • Programmatic management of latent tuberculosis infection in the European Union [2018]
    • Mathematical modelling of programmatic screening strategies for latent tuberculosis infection in countries with low tuberculosis incidence [2018]
    • Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA [2018]
  • EuroSurveillance
    • The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review [2018]
    • Identifying components for programmatic latent tuberculosis infection control in the European Union [2016]
  • TBNET
    • The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement [2012]
    • Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis [2011]
    • Tuberculosis contact investigation in low prevalence countries: a European consensus [2010]
    • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement [2010]
    • LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement [2009]
• India
  • BMJ Global Health
    • Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India [2018]
  • Indian Journal of Medical Ethics
    • Ethical issues in expanding latent TB management in high burden countries [2020]
  • Lung India
    • Management of latent tuberculosis infection: An evidence-based approach [2015]
• International
  • BMC Public Health
    • Global trends and gaps in research related to latent tuberculosis infection [2020]
  • BMJ Open
    • Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines [2018]
  • Bulletin of the World Health Organization
    • National policies on the management of latent tuberculosis infection: review of 98 countries [2018]
  • European Respiratory Journal
    • Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries [2015]
  • International Journal of Infectious Diseases
    • Preventive therapy for latent tuberculosis infection—the promise and the challenges [2017]
  • Lancet Infectious Diseases
    • Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling [2019]
  • PLoS Medicine
    • The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling [2016]
• Israel
  • Israel Medical Association Journal
    • Interferon Gamma Release Assay-Guided Latent Tuberculosis Prophylaxis in Israel [2015]
• Japan
  • Kekkaku (Tuberculosis)
    • Treatment guidelines for latent tuberculosis infection [2014]
  • PLoS ONE
    • Trend and treatment status of latent tuberculosis infection patients in Japan – Analysis of Japan TB Surveillance data [2017]
• Low and middle-income countries
  • Health Science Reports
    • How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers [2020]
  • PLoS ONE
    • Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis [2016]
• Netherlands
  • European Respiratory Journal
    • Yield of tuberculosis contact investigations in Amsterdam: opportunities for improvement [2014]
• Norway
  • BMC Infectious Diseases
    • Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study [2018]
  • BMJ Open
    • Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study [2019]
• Republic of Korea
  • Epidemiology and Health
    • An opposing view on including high school students in a latent tuberculosis infection control program in Korea [2017]
  • Journal of Preventive Medicine and Public Health
    • Proposal to Revise the Screening Test for Latent Tuberculosis Infection in Close Contacts at Elementary Schools in Korea [2019]
  • Tuberculosis and Respiratory Diseases
    • Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy [2018]
    • Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers [2016]
    • Diagnosis and Treatment of Latent Tuberculosis Infection [2015]
• Saudi Arabia
  • Saudi Thoracic Society
    • Saudi guidelines for testing and treatment of latent tuberculosis infection [2010]
• Singapore
  • International Journal of Infectious Diseases
    • Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey [2018]
• United Kingdom
  • Health Technology Assessment
    • Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation [2016]
  • Public Health England
    • Latent TB infection (LTBI): testing and treatment
• United States of America
  • Agency for Healthcare Research and Quality
    • Screening for Latent Tuberculosis Infection in Adults [2016]
  • American Journal of Nursing
    • Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States [2017]
  • Centers for Disease Control and Prevention
    • Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 [2020]
    • Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection [2018]
    • Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015 [2018]
    • Tuberculosis Contact Investigations — United States, 2003–2012 [2016]
    • Latent Tuberculosis Infection Resources
  • U.S. Preventive Services Task Force
    • Latent Tuberculosis Infection: Screening [2016]
• WHO
  • World Health Organization
    • Meeting of the Implementation Core Group of WHO Global Task Force on Latent TB Infection and country stakeholders on implementation tools and joint TB and HIV programming to scale up TB preventive treatment [2018]
    • Latent TB Infection : Updated and consolidated guidelines for programmatic management [2018]
• {Related topics}
  • Guidelines
    • Tuberculosis

Tuberculosis

• Afghanistan
  • Conflict and Health
    • Implementing a successful tuberculosis programme within primary care services in a conflict area using the stop TB strategy: Afghanistan case study [2014]
  • Public Health Action
    • Food assistance to tuberculosis patients: lessons from Afghanistan [2016]
• Africa
  • Indian Journal of Endocrinology and Metabolism
    • Endocrine dysfunction among adult patients with tuberculosis: An African experience [2014]
  • Infectious Diseases of Poverty
    • Productivity losses associated with tuberculosis deaths in the World Health Organization African region [2016]
  • WHO Regional Office for Africa
    • 2018 Africa Continental TB Scorecard [2019]
    • Framework for implementing the “End TB Strategy” in the African Region 2016 - 2020 [2017]
    • Tuberculosis (TB)
• Albania
  • WHO Regional Office for Europe
    • Mapping and reviewing roles and responsibilities of the main stakeholders of the National Tuberculosis Programme in Albania (2018) [2018]
• Armenia
  • Journal of Infection in Developing Countries
    • TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia [2013]
  • WHO Regional Office for Europe
    • Review of financial sustainability of tuberculosis activities in Armenia. Mission report (2018) [2018]
    • Extensive review of TB prevention, care and control services in Armenia [2012]
    • Tuberculosis assessment mission to Armenia [2005]
• Asia
  • PLoS ONE
    • Factors Associated with Patient and Provider Delays for Tuberculosis Diagnosis and Treatment in Asia: A Systematic Review and Meta-Analysis [2015]
• Australia
  • Department of Health Australia
    • How much does tuberculosis cost? An Australian healthcare perspective analysis [2017]
    • Tuberculosis (TB) - CDNA National Guidelines for Public Health Units [2015]
    • Essential components of a tuberculosis control program within Australia [2014]
  • NSW Health
    • Tuberculosis control guideline [2014]
    • Principles for the Management of Tuberculosis in New South Wales [2014]
• Azerbaijan
  • WHO Regional Office for Europe
    • Self-reliance review of tuberculosis prevention and care activities in Azerbaijan (2018) [2018]
    • Review of Tuberculosis Prevention, Control and Care in Azerbaijan [2013]
• Bangladesh
  • Indian Journal of Endocrinology and Metabolism
    • Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity [2016]
• Belarus
  • WHO Regional Office for Europe
    • Self-reliance review of tuberculosis activities in Belarus (2018) [2018]
    • Review of the national tuberculosis programme in Belarus. 8–18 December 2015 (2016) [2016]
    • Review of the National Tuberculosis Programme in Belarus [2012]
• Belize
  • Ministry of Health Belize
    • Tuberculosis Guidelines
• Bosnia and Herzegovina
  • WHO Regional Office for Europe
    • Review of the Tuberculosis Programme in Bosnia and Herzegovina [2014]
• Brazil
  • Jornal Brasileiro de Pneumologia
    • III Brazilian Thoracic Association Guidelines on Tuberculosis [2009]
  • Revista da Sociedade Brasileira de Medicina Tropical
    • Brazilian Response to Global End TB Strategy : The National Tuberculosis Research Agenda [2016]
• Cambodia
  • American Journal of Tropical Medicine and Hygiene
    • Cost-Effectiveness of a Tuberculosis Active Case Finding Program Targeting Household and Neighborhood Contacts in Cambodia [2014]
  • PLoS ONE
    • Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia [2016]
• Canada
  • Accelerating Change Transformation Team
    • Tuberculosis [2014]
  • BC Centre for Disease Control
    • Tuberculosis Manual
  • Public Health Agency of Canada
    • Tuberculosis (TB) [2017]
    • Canadian Tuberculosis Standards 7th Edition: 2014 [2014]
    • Tuberculosis: For health professionals
• China
  • BMC Public Health
    • Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients [2009]
  • Bulletin of the World Health Organization
    • Tuberculosis control in China: use of modelling to develop targets and policies [2015]
  • Infectious Diseases of Poverty
    • Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China [2016]
    • Access to and affordability of healthcare for TB patients in China: issues and challenges [2016]
  • PLoS ONE
    • China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data [2014]
• China, India, South Africa
  • Lancet Global Health
    • Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models [2016]
    • Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models [2016]
• Cuba
  • MEDICC Review
    • Impact of the 1970 Reforms to Cuba's National Tuberculosis Control Program [2015]
• Developing countries
  • PLoS Medicine
    • The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World [2012]
• Dominican Republic
  • Bulletin of the World Health Organization
    • Tuberculosis in the Dominican Republic: addressing the barriers to sustain the achievements [2007]
  • Revista Panamericana de Salud Pública
    • Health care workers' recommendations for strengthening tuberculosis infection control in the Dominican Republic [2018]
• Eastern Europe, Central Asia
  • WHO Regional Office for Europe
    • A people-centred model of TB care (2017) [2017]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Tuberculosis control in complex emergencies [2015]
• Estonia
  • WHO Regional Office for Europe
    • Collaborative action on tuberculosis and alcohol abuse in Estonia [2013]
    • Evaluation of fighting HIV/AIDS in Estonia [2008]
• Ethiopia
  • African Journal of Primary Health Care & Family Medicine
    • An audit of diagnosis and treatment of tuberculosis in Ethiopia [2014]
  • Infectious Diseases of Poverty
    • The impact of pastoralist mobility on tuberculosis control in Ethiopia: a systematic review and meta-synthesis [2019]
  • Journal of Infectious Diseases
    • Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis [2017]
• Europe
  • European Centre for Disease Prevention and Control
    • European Union Standards for Tuberculosis Care - 2017 update [2018]
    • Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings [2017]
    • Interventions in vulnerable groups are the key to eliminating tuberculosis in Europe [2016]
    • Guidance on tuberculosis control in vulnerable and hard-to-reach populations [2016]
  • European Respiratory Journal
    • Tuberculosis elimination: theory and practice in Europe [2014]
    • The European Union standards for tuberculosis care: do they need an update? [2014]
    • European Union Standards for Tuberculosis Care [2012]
  • EuroSurveillance
    • Ending tuberculosis in risk groups in Europe: challenges from travel and population movement [2017]
  • TBNET
    • The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis [2017]
  • WHO Regional Office for Europe
    • Tuberculosis elimination in the WHO European Region: review of key actions, with a special focus on management of tuberculosis infection (2020) [2020]
    • Fact sheet - Tuberculosis in the WHO European Region (2020) [2020]
    • Key political commitment documents for tuberculosis prevention and care and their intended influence in the WHO European Region (2019) [2019]
    • Defining the tuberculosis research agenda for the WHO European Region: a study report of the European TB Research Initiative (2019) [2019]
    • Compendium of good practices in the implementation of the Tuberculosis Action Plan for the WHO European Region 2016–2020 [2019]
    • What constitutes an effective and efficient package of services for the prevention, diagnosis, treatment and care of tuberculosis among refugees and migrants in the WHO European Region? Themed issues on migration and health, VIII (2018) [2018]
    • Technical Advisory Group on Tuberculosis for The WHO European Region. Report of the Eleventh Meeting (2017) [2017]
    • Roadmap to implement the tuberculosis action plan for the WHO European Region 2016–2020. Towards ending tuberculosis and multidrug-resistant tuberculosis (2016) [2016]
    • Regional workshop on tuberculosis, ethics and human rights [2014]
    • How health systems can address inequities in priority public health conditions : the example of tuberculosis : briefing on policy issues produced through the WHO/European Commission equity project [2010]
    • Addressing ethical issues in tuberculosis programmes with a special focus on social determinants : Meeting report, Athens, Greece 10-12 may 2010 [2010]
    • WHO European Ministerial Forum : "All against Tuberculosis" - Berlin Declaration on Tuberculosis [2008]
    • Plan to Stop TB in 18 High-priority Countries in the WHO European Region, 2007–2015 [2007]
    • Tuberculosis
• Fiji
  • Tropical Medicine and Infectious Disease
    • Strategic Planning for Tuberculosis Control in the Republic of Fiji [2019]
• Georgia
  • WHO Regional Office for Europe
    • Review of financial sustainability of tuberculosis activities in Georgia. Mission report (2018) [2018]
• Germany
  • Deutsches Ärzteblatt International
    • The Diagnosis and Treatment of Tuberculosis [2019]
• Greenland
  • WHO Regional Office for Europe
    • Tuberculosis prevention, control and care in Greenland. Report of a review mission (2016) [2016]
• High-income countries
  • Frontiers in Public Health
    • Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries? [2020]
• Hungary
  • WHO Regional Office for Europe
    • Extensive review of TB prevention, care and control services in Hungary [2013]
• India
  • Association of Physicians of India
    • Indian Scenario Management of Tuberculosis [2017]
  • Diabetes & Metabolic Syndrome: Clinical Research & Reviews
    • Tuberculosis in the era of COVID-19 in India [2020]
  • Indian Journal of Medical Research
    • Undernutrition & tuberculosis in India: Situation analysis & the way forward [2016]
    • Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium [2013]
    • New Vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - “Reaching the un-reached” [2012]
  • International Journal of Tuberculosis and Lung Disease
    • Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review [2014]
  • Journal of Association of Chest Physicians
    • Recent changes in technical and operational guidelines for tuberculosis control programme in India - 2016: A paradigm shift in tuberculosis control [2017]
  • Journal of Clinical and Diagnostic Research
    • Health Seeking Behaviour among Tuberculosis Patients in India: A Systematic Review [2016]
  • Ministry of Health and Family Welfare India
    • Technical and Operational Guidelines for TB Control in India 2016 [2016]
    • Index-TB Guidelines: Guidelines on extrapulmonary tuberculosis for India [2016]
  • PLoS Medicine
    • The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis [2016]
  • World Health Organization
    • A brief history of tuberculosis control in India [2010]
• Indonesia
  • BMC Research Notes
    • How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia [2015]
  • Global Health Action
    • The path to impact of operational research on tuberculosis control policies and practices in Indonesia [2016]
  • Journal of Infectious Diseases
    • Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public–Private Collaboration [2017]
• International
  • BMJ Global Health
    • International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review [2018]
  • Bulletin of the World Health Organization
    • Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda [2014]
    • Managing tuberculosis in people who use and inject illicit drugs [2013]
    • Transforming the global tuberculosis response through effective engagement of civil society organizations: the role of the World Health Organization [2011]
  • European Respiratory Journal
    • Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for Mycobacterial Infections (ESGMYC) [2020]
    • Towards tuberculosis elimination: an action framework for low-incidence countries [2015]
  • Infectious Disease Reports
    • Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination [2016]
  • International Union Against Tuberculosis and Lung Disease
    • Management of Tuberculosis: A Guide to Essential Practice [2019]
    • Management of Diabetes Mellitus-Tuberculosis – A Guide to the Essential Practice [2019]
    • Smoking cessation and smokefree environments for tuberculosis patients [2010]
    • Tuberculosis and public health: policy and principles in tuberculosis control [2009]
  • Médecins Sans Frontières
    • Tuberculosis: Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries [2017]
  • PLoS Medicine
    • Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions [2016]
  • Transactions of the Royal Society of Tropical Medicine and Hygiene
    • The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals [2016]
  • U.S. Agency for International Development
    • Tuberculosis
  • Virulence
    • Tackling tuberculosis: Insights from an international TB Summit in London [2015]
• Ireland
  • Health Protection Surveillance Centre
    • Guidelines on the Prevention and Control of Tuberculosis in Ireland, 2010  [2014]
• Japan
  • Nagoya Journal of Medical Science
    • Roles of public health centers (hokenjo) in tuberculosis control in Japan [2015]
• Kazakhstan
  • WHO Regional Office for Europe
    • Extensive review of tuberculosis prevention, control and care in Kazakhstan [2014]
• Kenya
  • Ministry of Health Kenya
    • Guidelines for Management of Tuberculosis and Leprosy in Kenya, July 2013 [2013]
• Kosovo
  • WHO Regional Office for Europe
    • Review of the Tuberculosis Programme in Kosovo [2014]
• Kyrgyzstan
  • WHO Regional Office for Europe
    • Review of tuberculosis prevention and care services in Kyrgyzstan, 30 June – 5 July 2014. Mission report [2015]
    • Review of the National TB Programme in Kyrgyzstan [2006]
• Latin America and the Caribbean
  • Revista Panamericana de Salud Pública
    • Determinants of tuberculosis in countries of Latin America and the Caribbean [2016]
• Low and middle-income countries
  • Infectious Diseases of Poverty
    • Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries [2020]
  • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    • User experience and patient satisfaction with tuberculosis care in low- and middle-income countries: A systematic review [2020]
  • PLoS Medicine
    • Research on Implementation of Interventions in Tuberculosis Control in Low- and Middle-Income Countries: A Systematic Review [2012]
  • PLoS ONE
    • Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study [2017]
• Low-income countries
  • International Union Against Tuberculosis and Lung Disease
    • Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries [2017]
• Macedonia
  • WHO Regional Office for Europe
    • Review of the national tuberculosis programme in the former Yugoslav Republic of Macedonia, 29 August–5 September 2016 [2016]
• Middle-income countries
  • Globalization and Health
    • Migration to middle-income countries and tuberculosis—global policies for global economies [2017]
• Moldova
  • WHO Regional Office for Europe
    • Self-reliance review of tuberculosis prevention and care activities in the Republic of Moldova. Mission Report (2019) [2019]
    • Review of the National Tuberculosis Programme in the Republic of Moldova [2013]
    • Joint tuberculosis control programme review mission to the Republic of Moldova [2012]
• Netherlands
  • European Centre for Disease Prevention and Control
    • Tuberculosis in the Netherlands [2020]
  • WHO Regional Office for Europe
    • Report of the joint WHO and ECDC programme review of the national TB control programme in the Netherlands [2014]
• New Zealand
  • Ministry of Health New Zealand
    • Guidelines for Tuberculosis Control in New Zealand, 2019 [2019]
    • Tuberculosis Case Management for People In Correctional Facilities [2018]
    • Tuberculosis
• Nigeria
  • Federal Ministry of Health
    • National Strategic Plan for Tuberculosis Control [2014]
• North Korea
  • Epidemiology and Health
    • A new strategy for tuberculosis control in North Korea [2015]
  • Health and Human Rights Journal
    • Rights-Based TB Programs for Migrants and Prisoners Needed in North Korea [2016]
  • WHO Regional Office for South-East Asia
    • National tuberculosis control programme: Democratic People's Republic of Korea [2015]
• Pacific Islands
  • WHO Western Pacific Region
    • Eighth TB Control Meeting for the Pacific Islands, Nadi, Fiji, 22-24 November 2016 : meeting report [2016]
• PAHO
  • Pan American Health Organization
    • Tuberculosis
• Pakistan
  • National TB Control Program
    • Online Resource Center
  • PLoS ONE
    • Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review [2018]
• Peru
  • European Respiratory Journal
    • The economic effects of supporting tuberculosis-affected households in Peru [2016]
• Philippines
  • Department of Health Philippines
    • National Tuberculosis Control Program Manual of Procedures [2014]
  • Journal of Infectious Diseases
    • Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines [2017]
  • Western Pacific Surveillance and Response Journal
    • Restarting the tuberculosis programme post-Haiyan [2015]
• Republic of Korea
  • Tuberculosis and Respiratory Diseases
    • Issues Related to the Updated 2014 Korean Guidelines for Tuberculosis [2015]
• Romania
  • WHO Regional Office for Europe
    • Improving payment mechanisms to support a new delivery model for TB care in Romania (2017) [2017]
    • Review of the national tuberculosis programme in Romania, 10–21 March 2014 [2015]
• Singapore
  • Ministry of Health Singapore
    • Prevention, Diagnosis and Management of Tuberculosis [2016]
  • SAGE Open Medicine
    • Is Singapore on track to eliminate tuberculosis by 2030? A policy case study [2019]
• South Africa
  • Health Research Policy and Systems
    • Setting priorities in health research using the model proposed by the World Health Organization: development of a quantitative methodology using tuberculosis in South Africa as a worked example [2016]
  • Journal of Infectious Diseases
    • The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges [2017]
  • PLoS ONE
    • Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa [2019]
• South-East Asia
  • Indian Journal of Medical Research
    • Strategies for ending tuberculosis in the South-East Asian Region: A modelling approach [2019]
  • WHO Regional Office for South-East Asia
    • Ending TB: Invest Now or Pay Later [2018]
    • Bending the Curve - Keeping our Promise of Ending TB in the South-East Asia Region on time [2018]
    • Tuberculosis: ‘Bending the Curve’ [2017]
    • Bending the curve: ending TB in the WHO South-East Asia Region [2017]
    • Tuberculosis control in the South-East Asia Region: annual report 2016 [2016]
    • Ending TB in the South-East Asia Region: Regional Strategic Plan 2016-2020 [2016]
    • Tuberculosis control: Report of a meeting of national programme managers and partners, New Delhi, India, 10-14 November 2014 [2015]
    • South-East Asia Regional Technical Working Group on Tuberculosis, Report of the fifth meeting, New Delhi, India, 28-29 April 2014 [2014]
    • Promoting the role of NGOs and CSOs in community-based TB care and control: Report of a regional workshop Jakarta, Indonesia, 18-20 Nov 2013 [2014]
    • Tuberculosis in SEARO
• Spain
  • Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
    • Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [2009]
• Sweden
  • International Journal of Infectious Diseases
    • The History of Tuberculosis Management in Sweden [2015]
• Taiwan
  • BMC Infectious Diseases
    • Health system delay among patients with tuberculosis in Taiwan: 2003–2010 [2015]
• Tajikistan
  • WHO Regional Office for Europe
    • Extensive review of tuberculosis prevention, control and care in Tajikistan, 15-24 July 2013 [2014]
    • Review of tuberculosis control in the Republic of Tajikistan [2009]
• Tanzania
  • Ministry of Health, Community Development, Gender, Elderly and Children
    • Operational Manual for Tuberculosis Care and prevention at Workplace [2018]
    • National Policy Guidelines for TB care and prevention at Workplace [2018]
    • National Guidelines for Tuberculosis Infection Control, Second Edition 2017 [2017]
  • WHO Regional Office for Africa
    • Monitoring the contribution of communities to the national TB response in Tanzania [2020]
• Timor-Leste
  • PLoS Medicine
    • Reconstructing Tuberculosis Services after Major Conflict: Experiences and Lessons Learned in East Timor [2006]
• Turkey
  • Tuberculosis and Thorax
    • The importance of associations in the struggle against tuberculosis in Turkey [2012]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Tuberculosis [2019]
    • Tuberculosis (Quality standard) [2017]
    • Identifying and managing tuberculosis among hard-to-reach groups [2012]
    • Tuberculosis
  • Public Health England
    • Tuberculosis: the green book, chapter 32
    • Tuberculosis in prisons: the role of Public Health England
    • Tuberculosis (TB): diagnosis, screening, management and data
    • Tuberculosis (TB) and homelessness
    • Tackling tuberculosis in under-served populations
  • Scottish Government
    • A TB action plan for Scotland [2011]
• Ukraine
  • WHO Regional Office for Europe
    • Review of the National Tuberculosis Programme in Ukraine (2011) [2012]
• United States of America
  • Centers for Disease Control and Prevention
    • Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts — United States, March–April 2020 [2020]
    • Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association [2020]
    • Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019 [2019]
    • Tuberculosis | National Prevention Information Network
    • Tuberculosis - Travelers' Health
    • Tuberculosis (TB)
  • Mass.gov
    • Tuberculosis
  • PLoS ONE
    • Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review [2018]
• Western Pacific
  • Respirology
    • Implementing the End TB Strategy in the Western Pacific Region: Translating vision into reality [2018]
  • Tropical Medicine and Infectious Disease
    • Action towards Universal Health Coverage and Social Protection for Tuberculosis Care and Prevention: Workshop on the End TB Strategy Pillar 2 in the Western Pacific Region 2017 [2018]
  • WHO Western Pacific Region
    • Eleventh National TB Programme Managers Meeting in the Western Pacific Region, Tokyo, Japan, 19-21 March 2017 : meeting report [2017]
    • Tuberculosis control in migrant populations : guiding principles and proposed actions [2016]
    • Tenth National TB Programme Managers Meeting in the Western Pacific Region, Manila, Philippines, 1-4 March 2016 : meeting report [2016]
    • Regional action plan for viral hepatitis in the Western Pacific 2016-2020 : a priority action plan for awareness, surveillance, prevention and treatment of viral hepatitis in the Western Pacific Region [2016]
    • Tuberculosis in Western Pacific
• WHO
  • World Health Organization
    • Multisectoral accountability framework to accelerate progress to end tuberculosis by 2030 [2020]
    • A Global Strategy for tuberculosis research and innovation [2020]
    • People-centred framework for tuberculosis programme planning and prioritization: user guide [2019]
    • Costing Guidelines for Tuberculosis Interventions [2019]
    • Public–private mix for TB prevention and care: a roadmap [2018]
    • Guidance for country-level TB modelling [2018]
    • Engaging private health care providers in TB care and prevention: a landscape analysis [2018]
    • Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis [2018]
    • Baseline assessment of community based TB services in 8 WHO ENGAGE-TB priority countries [2018]
    • Tuberculosis patient cost surveys: a handbook [2017]
    • Global investments in tuberculosis research and development: past, present and future. A policy paper prepared for the first WHO global ministerial conference on ending tuberculosis in the sustainable development era: a multisectoral response [2017]
    • Ethics guidance for the implementation of the End TB strategy [2017]
    • Digital health for the End TB strategy: progress since 2015 and future perspectives: meeting report, 7-8 February 2017 [2017]
    • Toolkit for developing a national TB research plan [2016]
    • On the road to ending TB: Highlights from the 30 highest TB burden countries [2016]
    • A Toolkit for Developing A National TB Research Plan, in support of the third pillar of the End TB Strategy [2016]
    • Training of community health workers and community volunteers - ENGAGE-TB: integrating community-based tuberculosis activities into the work of nongovernmental and other civil society organizations [2015]
    • Toolkit to develop a National Strategic Plan for TB prevention, care and control [2015]
    • Implementing the end TB strategy: the essentials [2015]
    • Empowering communities to end TB with the ENGAGE-TB approach [2015]
    • ENGAGE-TB: Training of community health workers and community volunteers [2015]
    • Digital health for the End TB Strategy - an agenda for action [2015]
    • A global action framework for TB research in support of the third pillar of WHO’s end TB strategy [2015]
    • International standards for tuberculosis care [2014]
    • Framework towards tuberculosis elimination in low-incidence countries [2014]
    • Framework for conducting reviews of tuberculosis programmes [2014]
    • Definitions and reporting framework for tuberculosis [2014]
    • Nutritional care and support for patients with tuberculosis [2013]
    • ENGAGE-TB Approach: Implementation manual [2013]
    • ENGAGE-TB Approach: Operational guidance [2012]
    • Manual on use of routine data quality assessment (RDQA) tool for TB monitoring [2011]
    • Collaborative framework for care and control of tuberculosis and diabetes [2011]
    • The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis [2010]
    • Public-Private Mix for TB Care and Control: report of the sixth meeting of the Subgroup on Public-Private Mix for TB Care and Control, Istanbul, Turkey, 16-18 February 2010 [2010]
    • Stop TB Partnership annual report 2008 [2009]
    • Stop TB policy paper: contributing to health system strengthening: guiding principles for national tuberculosis programmes [2008]
    • Stop TB Partnership annual report 2007 : gaining global momentum [2008]
    • Implementing the Stop TB Strategy: A handbook for national tuberculosis control programmes [2008]
    • Community involvement in tuberculosis care and prevention : towards partnerships for health : guiding principles and recommendations based on a WHO review [2008]
    • Stop TB coordination of technical assistance to countries : TBTEAM (TB Technical Assistance Mecanism) [2007]
    • Public-Private Mix for TB Care and Control: report of the Inter-Regional Planning Workshop on Public-private mix for tuberculosis control [2007]
    • Public-Private Mix for TB Care and Control : a tool for national situation assessment [2007]
    • Stop TB Partnership – Annual Report 2005 [2006]
    • Tuberculosis: Fact sheet
    • Tuberculosis (TB)
    • Nutrition assessment and counselling in individuals with active tuberculosis
    • Micronutrient supplementation in individuals with active tuberculosis
    • Management of severe acute malnutrition in individuals with active tuberculosis
    • Management of moderate undernutrition in individuals with active tuberculosis
    • Global Tuberculosis Programme
• Zambia
  • African Journal of Primary Health Care & Family Medicine
    • A survey to assess the extent of public-private mix DOTS in the management of tuberculosis in Zambia [2015]
• {Related topics}
  • Guidelines
    • Tuberculosis: treatment
    • Tuberculosis: screening, diagnosis
    • Tuberculosis: prevention, vaccine
    • Tuberculosis: epidemiology
    • Tuberculosis in children
    • Latent tuberculosis
    • HIV/AIDS and tuberculosis

Tuberculosis in children

• Afghanistan
  • PLoS ONE
    • Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan [2020]
• Africa
  • International Union Against Tuberculosis and Lung Disease
    • Desk guide for diagnosis and management of TB in children - Africa [2016]
• Asia
  • International Union Against Tuberculosis and Lung Disease
    • Desk guide for diagnosis and management of TB in children - Asia [2016]
• Bangladesh
  • BMC Public Health
    • Improving case detection of tuberculosis among children in Bangladesh: lessons learned through an implementation research [2017]
• Burkina Faso
  • Bulletin of the World Health Organization
    • Implementation of tuberculosis prevention for exposed children, Burkina Faso [2018]
• Canada
  • Canadian Paediatric Society
    • Tuberculosis among First Nations, Inuit and Métis children and youth in Canada: Beyond medical management [2020]
    • Approaches to detecting tuberculosis in children and youth [2018]
  • CMAJ
    • Diagnosis and management of pediatric tuberculosis in Canada [2017]
  • Paediatrics & Child Health
    • Epidemiology and clinical management of tuberculosis in children in Canada [2015]
  • Public Health Agency of Canada
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Pediatric Tuberculosis [2014]
• China
  • Journal of Pediatric Neurology and Medicine
    • The Current Situation of Diagnosis and Treatment of Tuberculosis in Childhood in China [2017]
• Denmark
  • European Respiratory Journal
    • A review of paediatric tuberculosis in Denmark: 10-year trend, 2000–2009 [2014]
• Europe
  • European Centre for Disease Prevention and Control
    • Guidance: Investigation and control of tuberculosis incidents affecting children in congregate settings [2013]
  • European Respiratory Journal
    • Prioritising children and adolescents in the tuberculosis response of the WHO European Region [2019]
    • Variation in policy and practice of adolescent tuberculosis management in the WHO European Region [2016]
  • WHO Regional Office for Europe
    • Regional workshop on child and adolescent tuberculosis in the WHO European Region (2020) [2020]
• India
  • Indian Academy of Pediatrics
    • Updated national guidelines for paediatric tuberculosis in India, 2012 [2013]
  • Indian Journal of Dermatology, Venereology and Leprology
    • Cutaneous tuberculosis in children: The Indian perspective [2010]
  • Indian Pediatrics
    • What Is New in the Management of Childhood Tuberculosis in 2020? [2020]
• International
  • BMC Infectious Diseases
    • Tuberculosis in childhood: a systematic review of national and international guidelines [2014]
  • Bulletin of the World Health Organization
    • Prevention of tuberculosis in household members: estimates of children eligible for treatment [2019]
  • Clinical Infectious Diseases
    • Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update [2015]
    • A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis [2015]
  • Infection and Drug Resistance
    • Epidemiology and disease burden of tuberculosis in children: a global perspective [2014]
  • International Journal of Tuberculosis and Lung Disease
    • Counting Children with Tuberculosis: Why Numbers Matter [2015]
  • International Union Against Tuberculosis and Lung Disease
    • A Framework for Integrating Childhood Tuberculosis into Community-based Health Care [2013]
  • Lancet Global Health
    • Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study [2018]
    • A new roadmap for childhood tuberculosis [2014]
  • Lancet Infectious Diseases
    • Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel [2015]
  • United Nations Children's Fund - UNICEF
    • Tuberculosis
• Italy
  • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    • How to manage children who have come into contact with patients affected by tuberculosis [2015]
• Kenya
  • Journal of Pediatrics
    • Epidemiology of Pediatric Tuberculosis in Kenya and Risk Factors for Mortality during Treatment: A National Retrospective Cohort Study [2018]
  • Ministry of Health Kenya
    • National guidelines on management of tuberculosis in children [2017]
• Low and middle-income countries
  • Bulletin of the World Health Organization
    • Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries: a systematic review and meta-analysis [2015]
• Malawi
  • Journal of Antimicrobial Chemotherapy
    • Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol [2015]
  • Pediatric Infectious Disease Journal
    • Use of Xpert® for the Diagnosis of Pulmonary Tuberculosis in Severely Malnourished Hospitalized Malawian Children [2014]
• New Zealand
  • Starship
    • Tuberculosis treatment [2017]
• Pakistan
  • BMC Research Notes
    • Are children with tuberculosis in Pakistan managed according to National programme policy guidelines? A study from 3 districts in Punjab [2010]
  • National TB Control Program
    • Doctor's Desk Guide-Management of Childhood Tuberculosis Pakistan [2017]
• South Africa
  • Department of Health South Africa
    • Guidelines for the management of tuberculosis in children, 2013 [2013]
  • Journal of Antimicrobial Chemotherapy
    • Subtherapeutic concentrations of first-line anti-TB drugs in South African children treated according to current guidelines: the PHATISA study [2014]
• Switzerland
  • Swiss Medical Weekly
    • Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines [2020]
• Taiwan
  • Journal of the Formosan Medical Association
    • Molecular diagnosis of childhood tuberculosis and infection with Bacilli Calmette-Guerin in Taiwan [2011]
    • Clinical perspectives of childhood tuberculosis in Taiwan [2011]
• Tanzania
  • Ministry of Health, Community Development, Gender, Elderly and Children
    • National guidelines for the management of tuberculosis in children [2016]
• United Kingdom
  • American Journal of Respiratory and Critical Care Medicine
    • Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study [2018]
  • Public Health England
    • Tuberculosis (TB) and children
• United States of America
  • American Academy of Pediatrics
    • Interferon-gamma Release Assays for Diagnosis of Tuberculosis Infection and Disease in Children [2014]
  • American College of Rheumatology
    • 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C [2013]
  • Centers for Disease Control and Prevention
    • TB in Children
  • Journal of Clinical Microbiology
    • Laboratory Diagnosis of Mycobacterium tuberculosis Infection and Disease in Children [2016]
  • Lancet Public Health
    • Epidemiology of tuberculosis among children and adolescents in the USA, 2007–17: an analysis of national surveillance data [2019]
• WHO
  • World Health Organization
    • Roadmap towards ending TB in children and adolescents [2018]
    • Best practices in child and adolescent tuberculosis care [2018]
    • Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children [2017]
    • Report of the annual meeting of the child and adolescent TB working group, 9 October 2017 [2017]
    • Technical step process to switch to new paediatric tuberculosis formulations [2016]
    • Report of the annual meeting of the childhood TB subgroup, Thursday 3 December 2015, Cape Town, South Africa [2016]
    • Guidance for national tuberculosis programmes on the management of tuberculosis in children [2014]
    • Childhood TB: Training Toolkit [2014]
    • Roadmap for Childhood TB: Toward zero deaths [2013]
    • Rapid advice: treatment of tuberculosis in children [2010]
• {Related topics}
  • Guidelines
    • Tuberculosis

Tuberculosis: drug resistance

• Africa
  • BMC Infectious Diseases
    • Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review [2020]
• Australia
  • Department of Health Australia
    • Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999–2018) [2020]
    • Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011: A report of the Australian Mycobacterium Reference Laboratory Network [2014]
    • National Tuberculosis Advisory Committee multi-drug resistant tuberculosis - Information Paper (October 2007) [2007]
  • Queensland Clinical Guidelines
    • Management of contacts of multidrug-resistant tuberculosis [2017]
• Azerbaijan
  • Public Health Action
    • First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis [2014]
• Bangladesh
  • Antibiotics
    • Prevalence of Antibiotic-Resistant Pulmonary Tuberculosis in Bangladesh: A Systematic Review and Meta-Analysis [2020]
  • WHO Regional Office for South-East Asia
    • First Bangladesh National Tuberculosis Drug Resistance Survey, 2010-2011 [2013]
• Belarus
  • Bulletin of the World Health Organization
    • Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors [2013]
• Brazil
  • Bulletin of the World Health Organization
    • Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil [2014]
  • Epidemiologia e Serviços de Saúde
    • Evaluation of the Drug-Resistant Tuberculosis Surveillance System, Brazil, 2013-2017 [2020]
  • Jornal Brasileiro de Pneumologia
    • Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines [2020]
• Canada
  • Public Health Agency of Canada
    • Tuberculosis drug resistance in Canada: 2018 [2020]
• Central Asia
  • Public Health Action
    • Challenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central Asia [2015]
• China
  • Biomedical and Environmental Sciences
    • Prevalence and Risk Factors of Primary Drug-Resistant Tuberculosis in China [2016]
  • BMC Infectious Diseases
    • Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China [2020]
    • Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis [2017]
  • Bulletin of the World Health Organization
    • Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China [2015]
  • Emerging Infectious Diseases
    • Drug-Resistant Tuberculosis among Children, China, 2006–2015 [2017]
  • Infectious Diseases of Poverty
    • Drug-resistant tuberculosis control in China: progress and challenges [2016]
  • Lancet Global Health
    • Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study [2015]
  • PLoS ONE
    • Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China [2019]
    • The Prevalence of Drug-Resistant Tuberculosis in Mainland China: An Updated Systematic Review and Meta-Analysis [2016]
    • Prevalence of Drug-Resistant Tuberculosis in Mainland China: Systematic Review and Meta-Analysis [2011]
• Côte d'Ivoire
  • BioMed Research International
    • Emergence in Western African Countries of MDR-TB, Focus on Côte d'Ivoire [2013]
• Dominican Republic
  • Revista Panamericana de Salud Pública
    • Culture and drug susceptibility testing among previously treated tuberculosis patients in the Dominican Republic, 2014 [2016]
• Eastern Africa
  • Tuberculosis
    • Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa [2014]
• Eastern Europe
  • Public Health Action
    • Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward [2014]
• Eastern Europe, Central Asia
  • Monaldi Archives for Chest Disease
    • Factors contributing to drug-resistant tuberculosis treatment outcome in five countries in the Eastern Europe and Central Asia region [2020]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region [2010]
• Estonia
  • European Respiratory Journal
    • Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia [2012]
  • Public Health Action
    • A four-year nationwide molecular epidemiological study in Estonia: risk factors for tuberculosis transmission [2014]
• Ethiopia
  • Antimicrobial Resistance and Infection Control
    • Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care [2014]
  • BMC Infectious Diseases
    • Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens [2018]
  • Tropical Diseases, Travel Medicine and Vaccines
    • Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome [2018]
• Ethiopia, South Africa
  • Bulletin of the World Health Organization
    • Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial [2020]
• Europe
  • Clinical Microbiology and Infection
    • Multidrug-resistant tuberculosis and migration to Europe [2017]
  • European Centre for Disease Prevention and Control
    • Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA [2017]
    • Healthcare system factors influencing treatment results of patients with multidrug-resistant tuberculosis [2014]
    • Management of contacts of MDR TB and XDR TB patients [2012]
  • EuroSurveillance
    • Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014 [2019]
    • Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015 [2017]
  • Revista Portuguesa de Pneumologia
    • Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond [2017]
  • TBNET
    • The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation [2019]
    • Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries [2018]
    • Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study [2017]
    • Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement [2016]
    • Multidrug-Resistant Tuberculosis in Europe, 2010–2011 [2015]
    • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement [2014]
    • Epidemiology and clinical management of XDR-TB: a systematic review by TBNET [2009]
  • WHO Regional Office for Europe
    • Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region (2019) [2019]
    • Regional Green Light Committee for the WHO European Region face-to-face meeting and workshop with high drug-resistant tuberculosis burden countries: programmatic aspects of the implementation of new tuberculosis drugs and regimens (2018) [2018]
    • Good practices in the prevention and care of tuberculosis and drug-resistant tuberculosis in correctional facilities (2018) [2018]
    • Regional Green Light Committee for the WHO European Region workshop and face-to-face meeting: Introduction of new medicines for the treatment of drug-resistant tuberculosis in the WHO European Region (2017) [2017]
    • European Tuberculosis Laboratory Initiative - Regional TB and MDR-TB Diagnosis Workshop Report (2017) [2017]
    • Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies (2017) [2017]
    • Good practices in strengthening health systems for the prevention and care of tuberculosis and drug-resistant tuberculosis (2015) [2015]
    • The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB [2014]
    • Regional workshop on models of care for multidrug-resistant tuberculosis [2014]
    • Best practices in prevention, control and care for drug-resistant tuberculosis. A resource for the continued implementation of the Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region, 2011–2015 [2013]
    • Roadmap to prevent and combat drug-resistant tuberculosis : the consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis in the WHO European Region 2011-2015 [2011]
    • Expert consultation on antimicrobial resistance: report on a meeting 25 August 2010 [2011]
    • Eighth meeting of national tuberculosis programme managers and thirteenth Wolfheze workshop : Wolfheze 2008 : tuberculosis management, surveillance and evaluation in Europe with high rates or threat of multidrug resistant tuberculosis [2008]
• Germany
  • PLoS ONE
    • First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017 [2019]
  • Respiratory Medicine
    • Cost of multi drug resistance tuberculosis in Germany [2014]
• Guatemala
  • Revista Panamericana de Salud Pública
    • Implementation of the national tuberculosis guidelines on culture and drug sensitivity testing in Guatemala, 2013 [2016]
• Guinea
  • Infection, Genetics and Evolution
    • First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea [2015]
• India
  • Association of Physicians of India
    • Drug Resistant Tuberculosis [2017]
  • BMC Public Health
    • Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis [2017]
  • Expert Review of Anti-infective Therapy
    • Managing drug-resistant tuberculosis: experiences from India [2010]
  • Indian Journal of Medical Research
    • Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management [2017]
  • Journal of Global Antimicrobial Resistance
    • National and sub-national level prevalence and patterns of drug resistant pulmonary tuberculosis - a systematic review and meta-analysis of Indian studies [2020]
  • Ministry of Health and Family Welfare India
    • Guidelines for use of Delamanid for treatment of DR-TB in India [2018]
    • Guidelines for Use of Bedaquiline in RNTCP PMDT in India [2016]
• Indonesia
  • EC Pulmonology and Respiratory Medicine
    • Management of Multidrug Resistant Tuberculosis in Paediatrics [2018]
• International
  • American Journal of Respiratory and Critical Care Medicine
    • New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations [2017]
  • BMC Medicine
    • Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis [2018]
  • Bulletin of the World Health Organization
    • Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis [2018]
    • Integrating tuberculosis and antimicrobial resistance control programmes [2018]
    • Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis [2017]
    • Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis [2016]
    • The need to accelerate access to new drugs for multidrug-resistant tuberculosis [2015]
    • Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility [2015]
    • Principles for designing future regimens for multidrug-resistant tuberculosis [2014]
    • Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010 [2012]
    • Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis [2012]
  • Emerging Infectious Diseases
    • Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis [2016]
    • Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs [2016]
    • Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries [2015]
  • European Respiratory Journal
    • Multidrug-resistant tuberculosis around the world: what progress has been made? [2014]
  • European Respiratory Review
    • Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives [2019]
    • Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences [2019]
  • Health and Human Rights Journal
    • Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy [2016]
  • International Journal of Infectious Diseases
    • MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network [2020]
  • International Union Against Tuberculosis and Lung Disease
    • Field Guide for the Management of Drug-Resistant Tuberculosis [2018]
    • Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis [2013]
    • DR-TB drugs under the microscope: the sources and prices of medicines [2013]
  • Lancet
    • Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates [2014]
  • Médecins Sans Frontières
    • New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid [2015]
    • Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries [2015]
  • Pediatrics
    • Global and Regional Burden of Isoniazid-Resistant Tuberculosis [2015]
  • PLoS Medicine
    • Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis [2018]
    • Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study [2015]
  • PLoS ONE
    • Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda [2016]
• Iran
  • Frontiers in Microbiology
    • First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review [2016]
  • Tanaffos
    • Management of MDR-TB: Review of Iran's Experience [2013]
• Italy
  • Infection and Drug Resistance
    • Advantages and Challenges of Tailored Regimens for Drug-Resistant Tuberculosis: A StopTB Italia Look into the Future [2020]
• Kenya
  • Ministry of Health Kenya
    • Programmatic Management of Drug Resistant Tuberculosis (PMDT) - Kenya. Third Edition, June 2014 [2014]
• Latvia
  • Bulletin of the World Health Organization
    • Treatment and management of MDR-TB in Latvia [2007]
  • Cost Effectiveness and Resource Allocation
    • The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia [2013]
  • Emerging Infectious Diseases
    • Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia [2016]
  • Public Health Action
    • Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes [2014]
• Lesotho
  • African Journal of Primary Health Care & Family Medicine
    • Knowledge and practices about multidrug-resistant tuberculosis amongst healthcare workers in Maseru [2015]
  • PLoS ONE
    • Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned [2015]
• Liberia
  • Microbial Genomics
    • Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events [2020]
• Lithuania
  • Medicina
    • Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead [2016]
• Low and middle-income countries
  • Transactions of the Royal Society of Tropical Medicine and Hygiene
    • Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings [2016]
• Madagascar
  • BMC Medicine
    • Multidrug-resistant tuberculosis surveillance and cascade of care in Madagascar: a five-year (2012–2017) retrospective study [2020]
• Malawi
  • Bulletin of the World Health Organization
    • Drug resistance of Mycobacterium tuberculosis in Malawi: a cross-sectional survey [2014]
• Mexico
  • Journal of Infection in Developing Countries
    • Drug resistant Mycobacterium tuberculosis in Mexico [2009]
  • Revista Panamericana de Salud Pública
    • Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013 [2016]
  • Salud Pública de México
    • Drug resistance and molecular epidemiology of Mycobacterium tuberculosis in Mexico: a systematic review [2014]
• Middle East
  • International Journal of Mycobacteriology
    • Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in Middle East countries [2016]
• Moldova
  • European Respiratory Journal
    • High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova [2014]
• Mongolia
  • Emerging Infectious Diseases
    • Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010–2011 [2015]
• Netherlands
  • Antimicrobial Resistance and Infection Control
    • Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015 [2019]
• Nigeria
  • BMC Infectious Diseases
    • Cost of three models of care for drug-resistant tuberculosis patients in Nigeria [2019]
  • PLoS ONE
    • Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria [2020]
    • Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved? [2015]
  • Tropical Medicine & International Health
    • Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria [2015]
• North Korea
  • PLoS Medicine
    • Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible? [2016]
    • The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea [2013]
• Pakistan
  • Journal of Pakistan Medical Association
    • Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan [2016]
  • National TB Control Program
    • Hand book of DR-TB practice [2017]
  • Public Health Action
    • Did diabetes mellitus affect treatment outcome in drug-resistant tuberculosis patients in Pakistan from 2010 to 2014? [2018]
    • Infection control in hospitals managing drug-resistant tuberculosis in Pakistan: how are we doing? [2017]
• Papua New Guinea
  • PLoS ONE
    • The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey [2016]
• Philippines
  • Department of Health Philippines
    • GeneXpert (Xpert MTB/Rif) in Multi-Drug Resistant Tuberculosis: Information Brief [2018]
• Portugal
  • BMC Infectious Diseases
    • A nationwide study of multidrug-resistant tuberculosis in Portugal 2014–2017 using epidemiological and molecular clustering analyses [2019]
• Republic of Korea
  • Tuberculosis and Respiratory Diseases
    • Treatment of Isoniazid-Resistant Pulmonary Tuberculosis [2020]
    • WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea [2017]
    • Medical Management of Drug-Resistant Tuberculosis [2015]
• Saudi Arabia
  • Antimicrobial Agents and Chemotherapy
    • Epidemiology of Antituberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey [2013]
• Singapore
  • Singapore Medical Journal
    • The imminent threat of multidrug-resistant tuberculosis in Singapore [2012]
• Somalia
  • Emerging Infectious Diseases
    • Multidrug-Resistant Tuberculosis, Somalia, 2010–2011 [2013]
• South Africa
  • Department of Health South Africa
    • Introduction of new drugs and drug regimensfor the management of drug-resistant tuberculosis in South Africa: Policy framework [2015]
    • Management of Drug-Resistant Tuberculosis - Policy Guidelines [2013]
  • International Journal of Infectious Diseases
    • Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register [2015]
  • International Journal of Tuberculosis and Lung Disease
    • Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005–2010 [2015]
    • A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa [2012]
  • Journal of Clinical Microbiology
    • Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa [2015]
  • PLoS ONE
    • What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa? [2013]
  • South African Medical Journal
    • Diagnosis and management of drug-resistant tuberculosis in South African adults [2014]
• South-East Asia
  • WHO Regional Office for South-East Asia
    • Capacity-building of affected communities for accelerated response to drug-resistant tuberculosis in the South-East Asia Region [2019]
    • Multidrug-resistant tuberculosis: Report of the 5th meeting of Regional Advisory Committee (r-GLC SEAR) on MDR-TB, Mumbai, 29-31 May 14 [2014]
    • Programmatic management of drug-resistant tuberculosis: Report of a regional workshop, Chiang Mai, Thailand, 17-21 September 2012 [2013]
    • Combating drug-resistant tuberculosis [2013]
• Spain
  • Archivos de Bronconeumología
    • Diagnosis and Treatment of Drug-Resistant Tuberculosis [2017]
  • Scientific Reports
    • The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain [2020]
• Sub-Saharan Africa
  • BMJ Global Health
    • Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review [2020]
  • PLoS ONE
    • Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis [2017]
• Swaziland
  • Emerging Infectious Diseases
    • High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010 [2012]
• Switzerland
  • Swiss Medical Weekly
    • Treatment outcomes of multidrug-resistant tuberculosis in Switzerland [2014]
• Taiwan
  • PLoS ONE
    • Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan [2019]
    • Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014 [2016]
• Tanzania
  • Ministry of Health, Community Development, Gender, Elderly and Children
    • Guidelines for Management of Multi Drug Resistant - TB in Tanzania, Second Edition 2018 [2018]
• Turkmenistan
  • WHO Regional Office for Europe
    • Multidrug-resistant tuberculosis in Turkmenistan: results of a nationwide survey, 2012 to 2013 (2015) [2015]
• Uganda
  • PLoS ONE
    • Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey [2013]
• United Kingdom
  • Emerging Infectious Diseases
    • Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000–2015 [2018]
  • EuroSurveillance
    • Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014 [2017]
  • Health Technology Assessment
    • Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis [2015]
  • NHS England
    • Bedaquiline and Delamanid for defined patients with MDR-TB and XDR-TB [2015]
  • PLoS ONE
    • Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK [2015]
  • QJM
    • Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999–2010 [2015]
  • UK Parliament
    • Drug Resistant Tuberculosis [2012]
• Ukraine
  • WHO Regional Office for Europe
    • Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB (2016) [2016]
• United States of America
  • Centers for Disease Control and Prevention
    • Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis [2013]
    • Interruptions in Supplies of Second-Line Antituberculosis Drugs — United States, 2005–2012 [2013]
    • Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013 [2013]
    • Drug-Resistant TB
  • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    • Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States [2019]
• Uzbekistan
  • EuroSurveillance
    • Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011 [2013]
• Vietnam
  • BMC Public Health
    • Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam [2015]
  • Western Pacific Surveillance and Response Journal
    • Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011 [2016]
• West Africa
  • BMC Medicine
    • The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance [2016]
• Western Pacific
  • WHO Western Pacific Region
    • Drug-resistant tuberculosis in the WHO Western Pacific Region [2014]
• WHO
  • World Health Organization
    • WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment [2020]
    • WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment [2020]
    • Rapid Communication: Molecular assays as initial tests for the diagnosis of tuberculosis and rifampicin resistance [2020]
    • Molecular assays intended as initial tests for the diagnosis of pulmonary and extrapulmonary TB and rifampicin resistance in adults and children: rapid communication [2020]
    • WHO consolidated guidelines on drug-resistant tuberculosis treatment [2019]
    • Evaluation of centralized assays for TB detection and detection of resistance to rifampicin and isoniazid [2019]
    • WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis [2018]
    • WHO Information Note on developing policy guidance for drug-resistant tuberculosis [2018]
    • The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide [2018]
    • Technical report on the pharmacokinetics and pharmacodynamics (PK/PD) of medicines used in the treatment of drug-resistant tuberculosis [2018]
    • Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis [2018]
    • Technical guide on next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex [2018]
    • Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) [2018]
    • WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert MTB/RIF ultra compared to Xpert MTB/RIF [2017]
    • WHO best-practice statement on the off-label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis [2017]
    • Report of the guideline development group meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: a review of available evidence (2016), 28 - 29 June 2016, Geneva, Switzerland [2017]
    • Xpert MTB/RIF assay for the diagnosis TB: meeting report [2016]
    • WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update [2016]
    • The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs [2016]
    • The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin [2016]
    • The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: Interim policy guidance [2016]
    • Guidelines for surveillance of drug resistance in tuberculosis - 5th edition [2015]
    • Framework for the engagement of all health care providers in the management of drug resistant tuberculosis [2015]
    • Best practices in engagement of all health care providers in the management of drug resistant tuberculosis [2015]
    • A situation assessment tool to engage all relevant care providers in drug-resistant tuberculosis (DR-TB) management at country level [2015]
    • Xpert MTB/RIF implementation manual [2014]
    • The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance [2014]
    • Management of drug-resistant tuberculosis - Training for staff working at DR-TB management centres [2014]
    • Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [2014]
    • Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children [2013]
    • Interim guidance on the use of bedaquiline to treat MDR-TB [2013]
    • Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update [2013]
    • Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015 : WHO progress report 2011 [2011]
    • Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'How-to'; practical considerations [2011]
    • Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system [2011]
    • Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement [2011]
    • Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update [2011]
    • Checklist of prerequisites to country implementation of Xpert MTB/RIF and key action points at country level [2011]
    • Multidrug-resistant tuberculosis (MDR-TB) indicators: a minimum set of indicators for the programmatic management of MDR-TB in national tuberculosis control programmes [2010]
    • Multidrug and extensively drug-resistant TB (M/XDR-TB) : 2010 global report on surveillance and response [2010]
    • Green light committee initiative of the working group on multidrug-resistant tuberculosis of the Stop TB partnership: annual report 2009 [2010]
    • Management of MDR-TB: A field guide [2009]
    • Green light committee initiative of the working group on MDR-TB of the Stop TB partnership: annual report 2008 [2009]
    • Global tuberculosis control and patient care : meeting report : a ministerial meeting of high M/XDR-TB burden countries [2009]
    • Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs [2008]
    • Guidelines for the programmatic management of drug-resistant tuberculosis [2008]
    • Green light committee initiative of the working group on MDR-TB of the Stop TB partnership: annual report 2007 [2008]
    • Anti-tuberculosis drug resistance in the world : fourth global report [2008]
    • The global MDR-TB & XDR-TB response plan 2007-2008 [2007]
    • Drug-resistant tuberculosis
    • Drug resistant TB - Data by country
• Zambia
  • Tropical Medicine & International Health
    • The Second Zambian National Tuberculosis Drug Resistance survey – a comparison of conventional and molecular methods [2015]
    • Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011 [2013]
• {Related topics}
  • Guidelines
    • Tuberculosis: treatment

Tuberculosis: epidemiology

• Afghanistan
  • PLoS ONE
    • An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan [2016]
• Africa
  • International Journal of Molecular Epidemiology and Genetics
    • Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review [2020]
  • PLoS ONE
    • Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis [2019]
• Albania
  • Management in Health
    • Distribution of tuberculosis cases in Albania during 2012-2013 [2014]
• America
  • Pan American Health Organization
    • Tuberculosis in the Americas. 2019 Regional Report [2020]
• Armenia
  • Public Health Action
    • Performance of decentralised facilities in tuberculosis case notification and treatment success in Armenia [2014]
• Australia
  • Department of Health Australia
    • The epidemiology of tuberculosis in the Australia Capital Territory, 2006-2015 [2017]
    • Tuberculosis notifications in Australia annual reports
  • PLoS ONE
    • Epidemiology, Diagnosis and Management of Extra-Pulmonary Tuberculosis in a Low-Prevalence Country: A Four Year Retrospective Study in an Australian Tertiary Infectious Diseases Unit [2016]
• Bahrain
  • Journal of Tuberculosis and Therapeutics
    • Epidemiology of Tuberculosis in Bahrain and Pre-employment Screening [2018]
• Belize
  • Ministry of Health Belize
    • Tuberculosis Statistical Report: Comparative Review 2008-2009 [2010]
• Benin
  • Tuberculosis Research and Treatment
    • Tuberculosis Case Finding in Benin, 2000–2014 and Beyond: A Retrospective Cohort and Time Series Study [2016]
• Bosnia and Herzegovina
  • Materia Socio-Medica
    • Epidemiology of Tuberculosis During the Period 1703–2011: Honoring the World Tuberculosis Day [2013]
• Brazil
  • BMJ Open
    • Identifying socioeconomic, epidemiological and operational scenarios for tuberculosis control in Brazil: an ecological study [2018]
  • PLoS ONE
    • Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates [2019]
    • Ethnic and Racial Inequalities in Notified Cases of Tuberculosis in Brazil [2016]
  • Population Health Metrics
    • The burden of tuberculosis and attributable risk factors in Brazil, 1990–2017: results from the Global Burden of Disease Study 2017 [2020]
• Burundi
  • Clinical Infectious Diseases
    • Tuberculosis Incidence at the Burundi-Rwanda Border 15 Years After the Civil War [2012]
• Cambodia
  • Bulletin of the World Health Organization
    • Cross-sectional studies of tuberculosis prevalence in Cambodia between 2002 and 2011 [2014]
  • Western Pacific Surveillance and Response Journal
    • Tuberculosis case-finding in Cambodia: analysis of case notification data, 2000 to 2013 [2015]
• Canada
  • Journal of Public Health Research
    • Tuberculosis in Quebec: a Review of Trends [2012]
  • Public Health Agency of Canada
    • Tuberculosis in Canada - Summary 2015 [2017]
    • Tuberculosis in Canada: 2015 Supplementary data [2017]
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Epidemiology of Tuberculosis in Canada [2014]
    • Tuberculosis: Monitoring
• China
  • BMC Public Health
    • Epidemiological characteristics of pulmonary tuberculosis in mainland China from 2004 to 2015: a model-based analysis [2019]
  • BMJ Open
    • Under-reporting of diagnosed tuberculosis to the national surveillance system in China: an inventory study in nine counties in 2015 [2019]
    • Temporal trends analysis of tuberculosis morbidity in mainland China from 1997 to 2025 using a new SARIMA-NARNNX hybrid model [2019]
  • Chinese Medical Journal
    • Notification Rate of Tuberculosis among Migrants in China 2005–2014: A Systematic Review and Meta-analysis [2016]
  • Infection and Drug Resistance
    • Secular Seasonality and Trend Forecasting of Tuberculosis Incidence Rate in China Using the Advanced Error-Trend-Seasonal Framework [2020]
  • Infectious Diseases of Poverty
    • Spatial inequality, characteristics of internal migration, and pulmonary tuberculosis in China, 2011–2017: a spatial analysis [2020]
  • International Journal of Infectious Diseases
    • Analysis on spatial-temporal distribution characteristics of smear positive pulmonary tuberculosis in China, 2004–2015 [2019]
  • Lancet Global Health
    • Prevalence of pulmonary tuberculosis in western China in 2010-11: a population-based, cross-sectional survey [2016]
  • PLoS ONE
    • The epidemiology of extrapulmonary tuberculosis in China: A large-scale multi-center observational study [2020]
  • Scientific Reports
    • The burden and challenges of tuberculosis in China: findings from the Global Burden of Disease Study 2015 [2017]
  • Therapeutics and Clinical Risk Management
    • Frequency of tuberculosis among diabetic patients in the People’s Republic of China [2014]
• Cuba
  • MEDICC Review
    • New indicators proposed to assess tuberculosis control and elimination in Cuba [2012]
    • Tuberculosis mortality trends in Cuba, 1998 to 2007 [2009]
• Denmark
  • EuroSurveillance
    • Tuberculosis incidence among migrants according to migrant status: a cohort study, Denmark, 1993 to 2015 [2019]
  • International Journal of Infectious Diseases
    • The economic burden of Tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses [2015]
  • PLoS ONE
    • Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study [2020]
• Eritrea
  • Bulletin of the World Health Organization
    • Determining the burden of tuberculosis in Eritrea: a new approach [2007]
  • Emerging Infectious Diseases
    • Evaluating Tuberculosis Case Detection in Eritrea [2007]
• Ethiopia
  • BMC Infectious Diseases
    • Spoligotyping based genetic diversity of Mycobacterium tuberculosis in Ethiopia: a systematic review [2018]
  • Ethiopian Journal of Health Sciences
    • Tuberculosis Burden in Ethiopia from 1990 to 2016: Evidence from the Global Burden of Diseases 2016 Study [2018]
• Europe
  • Bulletin of the World Health Organization
    • Tuberculosis control and economic recession: longitudinal study of data from 21 European countries, 1991–2012 [2015]
  • European Centre for Disease Prevention and Control
    • Tuberculosis surveillance and monitoring in Europe 2020 –2018 data [2020]
    • Tuberculosis - Annual Epidemiological Report for 2018 [2020]
    • Social determinants and risk factors in tuberculosis surveillance in the EU/EEA [2018]
    • Tuberculosis in Europe: from passive control to active elimination – high- and low-incidence countries [2015]
    • Annual epidemiological report 2014 – respiratory tract infections – tuberculosis [2015]
  • European Journal of Public Health
    • Tuberculosis among migrant populations in the European Union and the European Economic Area [2014]
  • EuroSurveillance
    • Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016 [2020]
    • Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030? [2019]
    • Tuberculosis in the European Union/European Economic Area: much progress, still many challenges [2019]
    • Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015 [2017]
    • The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013 [2016]
    • Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013 [2016]
    • Impact of migration on tuberculosis epidemiology and control in the EU/EEA [2016]
  • PLoS ONE
    • Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014 [2017]
  • Public Health Action
    • Social determinants and risk factors for tuberculosis in national surveillance systems in Europe [2015]
  • WHO Regional Office for Europe
    • Tuberculosis surveillance and monitoring report in Europe 2020 [2020]
    • Annual meeting of the European Network for TB surveillance in Europe: Dubrovnik, Croatia 25-26 May 2009 : report [2009]
• Fiji
  • Emerging Infectious Diseases
    • Tuberculosis, Fiji, 2002–2013 [2016]
• Finland
  • BMC Infectious Diseases
    • Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study [2017]
  • PLoS ONE
    • Molecular Epidemiology of Tuberculosis in Finland, 2008-2011 [2013]
• Gambia
  • Bulletin of the World Health Organization
    • A tuberculosis nationwide prevalence survey in Gambia, 2012 [2016]
• Georgia
  • WHO Regional Office for Europe
    • Analysis of the epidemiological impact of tuberculosis in Georgia (2016) [2016]
• Germany
  • BMC Infectious Diseases
    • Completeness of tuberculosis case notifications in Germany in 2013–2017: first results of an inventory study [2020]
  • European Journal of Microbiology & Immunology
    • Tuberculosis surveillance and control in Germany – An application of the Berlin Declaration Monitoring and Evaluation Framework [2012]
  • EuroSurveillance
    • The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009 [2013]
  • International Journal of Environmental Research and Public Health
    • Tuberculosis among Health Workers—A Secondary Data Analysis of German Social Accident Insurance Data from 2002–2017 [2020]
  • Journal of Occupational Medicine and Toxicology
    • Tuberculosis in healthcare workers – a narrative review from a German perspective [2014]
  • Robert Koch Institute
    • Report on the Epidemiology of Tuberculosis in Germany - 2017 [2018]
• Greenland
  • WHO Regional Office for Europe
    • Tuberculosis control in Greenland [2011]
• Haiti
  • Bulletin of the World Health Organization
    • Tuberculosis in the aftermath of the 2010 earthquake in Haiti [2015]
  • International Journal of Tuberculosis and Lung Disease
    • Evaluation of the national tuberculosis surveillance program in Haiti [2015]
• High-income countries
  • BMC Medicine
    • The impact of migration on tuberculosis epidemiology and control in high-income countries: a review [2016]
• India
  • BMJ Global Health
    • Tuberculosis case fatality in India: a systematic review and meta-analysis [2020]
    • India’s syndemic of tuberculosis and COVID-19 [2020]
  • Bulletin of the World Health Organization
    • Improving the estimation of the tuberculosis burden in India [2014]
• International
  • BMC Infectious Diseases
    • Does tuberculosis threaten our ageing populations? [2016]
  • BMC Medicine
    • Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review [2018]
    • Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis [2018]
  • Bulletin of the World Health Organization
    • Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality [2011]
    • Tuberculosis in the WHO South-East Asia Region [2010]
    • Trends in tuberculosis incidence and their determinants in 134 countries [2009]
    • The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection [2009]
  • Centers for Disease Control and Prevention
    • Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets — Worldwide, 2018 [2020]
  • Lancet Global Health
    • Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review [2019]
    • The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1 [2018]
  • Lancet Infectious Diseases
    • The impact of social protection on tuberculosis rates: a global analysis [2015]
  • Seminars in Respiratory and Critical Care Medicine
    • Global Epidemiology of Tuberculosis [2018]
  • TB Facts
    • TB statistics
• Iran
  • International Journal of Preventive Medicine
    • Trend of Smear-positive Pulmonary Tuberculosis in Iran during 1995–2012: A Segmented Regression Model [2016]
  • Iranian Journal of Public Health
    • Predicting the Incidence of Smear Positive Tuberculosis Cases in Iran Using Time Series Analysis [2015]
    • Pattern of Reported Tuberculosis Cases in Iran 2009–2010 [2013]
  • Journal of Research in Health Sciences
    • Trend of some Tuberculosis Indices in Iran during 25 yr Period (1990-2014) [2016]
• Ireland
  • Health Protection Surveillance Centre
    • Tuberculosis (TB)
• Japan
  • Western Pacific Surveillance and Response Journal
    • Pulmonary tuberculosis and non-recent immigrants in Japan – some issues for post-entry interventions [2017]
• Kazakhstan
  • BMC Infectious Diseases
    • Tuberculosis in Kazakhstan: analysis of risk determinants in national surveillance data [2012]
  • WHO Regional Office for Europe
    • Tuberculosis epidemiological impact analysis and assessment of TB surveillance system of Kazakhstan, 2017 (2019) [2019]
• Kenya
  • Bulletin of the World Health Organization
    • New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya [2009]
• Kiribati
  • International Journal of Infectious Diseases
    • Battling tuberculosis in an island context with a high burden of communicable and non-communicable diseases: epidemiology, progress, and lessons learned in Kiribati, 2000 to 2012 [2015]
• Kosovo
  • Materia Socio-Medica
    • Tuberculosis Incidence and Case Notification Rates in Kosovo and the Balkans in 2012: Cross-country Comparison [2014]
• Laos
  • Tropical Medicine & International Health
    • The first national tuberculosis prevalence survey of Lao PDR (2010–2011) [2015]
• Latin America
  • Genes
    • Tuberculosis Genetic Epidemiology: A Latin American Perspective [2019]
• Latin America and the Caribbean
  • Revista Panamericana de Salud Pública
    • Social determinants and inequalities in tuberculosis incidence in Latin America and the Caribbean [2015]
• Low and middle-income countries
  • Bulletin of the World Health Organization
    • Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis [2014]
  • PLoS Medicine
    • Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis [2016]
• Mexico
  • Canadian Respiratory Journal
    • Morbidity Trends and Risk of Tuberculosis: Mexico 2007–2017 [2019]
  • PLoS ONE
    • Association of Pulmonary Tuberculosis and Diabetes in Mexico: Analysis of the National Tuberculosis Registry 2000–2012 [2015]
• Mexico, United States of America
  • Tuberculosis and Respiratory Diseases
    • Tuberculosis in Mexico and the USA, Comparison of Trends Over Time 1990-2010 [2015]
• Middle East
  • International Journal of Infectious Diseases
    • Diabetes-related tuberculosis in the Middle East: an urgent need for regional research [2015]
• Moldova
  • Bulletin of the World Health Organization
    • Increasing tuberculosis case detection: lessons from the Republic of Moldova [2008]
  • WHO Regional Office for Europe
    • Analysis of the epidemiological impact of tuberculosis in the Republic of Moldova (2017) [2017]
• Myanmar
  • BMC Infectious Diseases
    • Are current case-finding methods under-diagnosing tuberculosis among women in Myanmar? An analysis of operational data from Yangon and the nationwide prevalence survey [2016]
• New Zealand
  • Public Health Surveillance
    • Tuberculosis in New Zealand Annual Reports
• Nigeria
  • Federal Ministry of Health
    • Report first national TB prevalence survey 2012, Nigeria [2016]
  • Tropical Medicine & International Health
    • Tuberculosis case detection in Nigeria, the unfinished agenda [2015]
• Norway
  • BMC Public Health
    • Description of the largest cluster of tuberculosis notified in Norway 1997–2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? [2015]
• Pacific Islands
  • Western Pacific Surveillance and Response Journal
    • The epidemiology of tuberculosis in the Pacific, 2000 to 2013 [2015]
• Pakistan
  • Journal of Ayub Medical College Abbottabad
    • Spatial cluster analysis of new and relapsed cases of pulmonary tuberculosis by district: Pakistan 2015 [2019]
  • Pakistan Bureau of Statistics
    • T.B Report
  • PLoS ONE
    • Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010–2011 [2016]
• Papua New Guinea
  • Western Pacific Surveillance and Response Journal
    • Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008–2016 [2018]
• Philippines
  • Western Pacific Surveillance and Response Journal
    • Tuberculosis among children, adolescents and young adults in the Philippines: a surveillance report [2018]
    • The tuberculosis profile of the Philippines, 2003–2011: advancing DOTS and beyond [2013]
• Republic of Korea
  • Emerging Infectious Diseases
    • Achievements in and Challenges of Tuberculosis Control in South Korea [2015]
  • Osong Public Health and Research Perspectives
    • Tuberculosis Notification Completeness and Timeliness in the Republic of Korea During 2012–2014 [2016]
  • Tuberculosis and Respiratory Diseases
    • Increased Tuberculosis Burden Due to Demographic Transition in Korea from 2001 to 2010 [2013]
• Russia
  • Bulletin of the World Health Organization
    • Variations in tuberculosis prevalence, Russian Federation: a multivariate approach [2019]
  • Clinical Microbiology Reviews
    • Insights into the Origin, Emergence, and Current Spread of a Successful Russian Clone of Mycobacterium tuberculosis [2013]
• Rwanda
  • Ministry of Health Rwanda
    • Tuberculosis may be underestimated in Rwandan women [2011]
• Saudi Arabia
  • Annals of Thoracic Medicine
    • Tuberculosis incidence trends in Saudi Arabia over 20 years: 1991-2010 [2013]
  • International Journal of Mycobacteriology
    • Mapping the epidemiology and trends of extra-pulmonary tuberculosis in Saudi Arabia [2015]
  • Journal of Infection in Developing Countries
    • Tuberculosis in Saudi Arabia: the journey across time [2015]
• Serbia
  • EuroSurveillance
    • Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015 [2020]
• Singapore
  • BMC Public Health
    • Time series analysis of demographic and temporal trends of tuberculosis in Singapore [2014]
  • Singapore Medical Journal
    • TB control in Singapore: where do we go from here? [2012]
    • TB Control in Singapore: the high price of diagnostic delay [2012]
• Solomon Islands
  • Public Health Action
    • Tuberculosis notifications, characteristics and treatment outcomes: urban vs. rural Solomon Islands, 2000–2011 [2014]
• South Africa
  • BMC Health Services Research
    • The epidemiology of tuberculosis in health care workers in South Africa: a systematic review [2016]
  • BMC Public Health
    • TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response [2018]
    • Completeness and Reliability of the Republic of South Africa National Tuberculosis (TB) Surveillance System [2015]
  • BMJ Global Health
    • Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review [2020]
• Tanzania
  • Ministry of Health, Community Development, Gender, Elderly and Children
    • TB Prevalence in Tanzania
• Turkey
  • Journal of Infection in Developing Countries
    • Effect of human development index parameters on tuberculosis incidence in Turkish provinces [2016]
• United Kingdom
  • BMC Medicine
    • Recent household transmission of tuberculosis in England, 2010–2012: retrospective national cohort study combining epidemiological and molecular strain typing data [2017]
  • ERJ Open Research
    • Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data [2019]
  • EuroSurveillance
    • Creating a web-based electronic tool to aid tuberculosis (TB) cluster investigation: data integration in TB surveillance activities in the United Kingdom, 2013 to 2016 [2018]
  • HSC Public Health Agency
    • Epidemiology of Tuberculosis in Northern Ireland, Annual Surveillance Report 2016 [2018]
  • Lancet
    • Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519?955 migrants screened before entry to England, Wales, and Northern Ireland [2016]
  • Public Health England
    • Tuberculosis: notifying cases
    • Tuberculosis (TB): national strain typing service
    • Tuberculosis (TB) in the UK: annual report
    • Tuberculosis (TB) in England: ad hoc provisional data
    • Enhanced TB surveillance strain typing module: user guide
• Ukraine
  • ERJ Open Research
    • Clinical manifestations and epidemiology of adolescent tuberculosis in Ukraine [2020]
• United States of America, United Kingdom
  • Thorax
    • Mind the gap: TB trends in the USA and the UK, 2000–2011 [2016]
• United States of America
  • American Journal of Epidemiology
    • Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model [2018]
  • Centers for Disease Control and Prevention
    • US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012–2016 [2020]
    • Tuberculosis — United States, 2019 [2020]
    • Tuberculosis — United States, 2018 [2019]
    • Tuberculosis — United States, 2017 [2018]
    • Tuberculosis — United States, 2016 [2017]
    • Tuberculosis Caused by Mycobacterium africanum, United States, 2004–2013 [2016]
    • Leveling of Tuberculosis Incidence — United States, 2013–2015 [2016]
    • Tuberculosis Trends — United States, 2014 [2015]
    • Trends in Tuberculosis — United States, 2013 [2014]
    • Trends in Tuberculosis — United States, 2012 [2013]
    • Tuberculosis Genotyping — United States, 2004–2010 [2012]
    • Trends in Tuberculosis — United States, 2011 [2012]
    • Tuberculosis Outbreak Investigations in the United States, 2002–2008 [2011]
    • TB | Data and Statistics
  • Epidemics
    • High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000–2016 [2020]
  • JMIR Public Health and Surveillance
    • The US National Tuberculosis Surveillance System: A Descriptive Assessment of the Completeness and Consistency of Data Reported from 2008 to 2012 [2015]
  • Journal of Infection and Public Health
    • Pulmonary vs. extra-pulmonary tuberculosis hospitalizations in the US [1998–2014] [2019]
  • PLoS ONE
    • Recent Transmission of Tuberculosis — United States, 2011–2014 [2016]
    • Abrupt Decline in Tuberculosis among Foreign-Born Persons in the United States [2016]
    • Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012 [2015]
• Vanuatu
  • Public Health Action
    • Tuberculosis case burden and treatment outcomes in children, adults and older adults, Vanuatu, 2007–2011 [2014]
• Vietnam
  • Bulletin of the World Health Organization
    • National survey of tuberculosis prevalence in Viet Nam [2010]
  • Western Pacific Surveillance and Response Journal
    • Tuberculosis case notification data in Viet Nam, 2007 to 2012 [2015]
• Western Pacific
  • WHO Western Pacific Region
    • Epidemiology and control of tuberculosis in the Western Pacific Region: update with 2013 case notification data [2016]
• WHO
  • World Health Organization
    • Global tuberculosis report 2020 [2020]
    • Understanding and using tuberculosis data [2014]
    • Standards and benchmarks for tuberculosis surveillance and vital registration systems [2014]
    • Electronic recording and reporting for tuberculosis care and control [2012]
    • Assessing tuberculosis under-reporting through inventory studies [2012]
    • Tuberculosis prevalence surveys: a handbook [2011]
    • Tuberculosis data
    • Tuberculosis - Global Health Observatory data repository
    • TB country profiles
• Zambia
  • PLoS ONE
    • The Prevalence of Tuberculosis in Zambia: Results from the First National TB Prevalence Survey, 2013–2014 [2016]
• Zimbabwe
  • BMC Research Notes
    • Trends of sputum-smear positive tuberculosis in Zimbabwe: 2008–2011 [2015]
• {Related topics}
  • Guidelines
    • Tuberculosis

Tuberculosis: prevention, vaccine

• Australia
  • Australian Family Physician
    • Tuberculosis – prevention in travellers [2010]
  • Australian Journal of General Practice
    • BCG vaccination: An update on current Australian practices [2020]
  • Department of Health Australia
    • Tuberculosis | The Australian Immunisation Handbook [2018]
    • Evaluation of bacille Calmette-Guérin immunisation programs in Australia [2017]
    • Adverse events following immunisation with BCG vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine [2016]
    • The BCG vaccine: information and recommendations for use in Australia [2013]
  • NSW Health
    • Tuberculosis Contact Investigations [2019]
    • Tuberculosis Management of People Knowingly Placing Others at Risk of Infection [2015]
• Canada
  • BMC Public Health
    • A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities [2019]
  • Canadian Agency for Drugs and Technologies in Health
    • Home Isolation to Prevent Tuberculosis Transmission: A Review of the Clinical Evidence and Guidelines [2014]
  • Public Health Agency of Canada
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Prevention and control of Tuberculosis transmission in health care and other settings [2014]
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Bacille Calmette-Guérin (BCG) vaccination in Canada [2014]
  • Vaccine
    • Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956–1974 [2017]
• China
  • Lancet Global Health
    • Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study [2019]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Stop tuberculosis
• Europe
  • European Respiratory Journal
    • Bacille Calmette–Guérin vaccination: the current situation in Europe [2014]
  • EuroSurveillance
    • Systematic review on tuberculosis transmission on aircraft and update of the European Centre for Disease Prevention and Control risk assessment guidelines for tuberculosis transmitted on aircraft (RAGIDA-TB) [2016]
  • WHO Regional Office for Europe
    • Guiding principles to reduce tuberculosis transmission in the WHO European Region (2018) [2018]
    • Regional workshop on results-based management for tuberculosis prevention, care and control [2014]
• France
  • EuroSurveillance
    • Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011 [2015]
• Indonesia
  • Vaccines
    • Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study [2020]
• International
  • American Journal of Epidemiology
    • Vaccination and All-Cause Child Mortality From 1985 to 2011: Global Evidence From the Demographic and Health Surveys [2015]
  • BCG World Atlas
    • BCG World Atlas
  • BMC Medicine
    • The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality [2016]
  • Clinical Infectious Diseases
    • Consensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials [2012]
  • PLoS Medicine
    • The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices [2011]
• Iran
  • Advanced Biomedical Research
    • Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis [2016]
• Ireland
  • Archives of Public Health
    • Evaluating the neonatal BCG vaccination programme in Ireland [2016]
  • Health Information and Quality Authority
    • HTA of BCG Vaccination Programme [2015]
  • Health Protection Surveillance Centre
    • BCG Vaccination: Protection against TB
  • Ireland's Health Services
    • Tuberculosis [2015]
• Italy
  • Human Vaccines & Immunotherapeutics
    • Recommendations for pediatric tuberculosis vaccination in Italy [2015]
  • Journal of Preventive Medicine and Hygiene
    • Current preventive policies and practices against Vaccine-Preventable Diseases and tuberculosis targeted for workers from hospitals of the Sardinia Region, Italy [2016]
• Kenya
  • Ministry of Health Kenya
    • Guidelines for TB infection Prevention and Control for Health Care workers in Kenya. July 2014 [2014]
• Low and middle-income countries
  • PLoS ONE
    • Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review [2020]
• Low-income countries
  • Journal of Infection and Public Health
    • Reflecting on the updates to the World Health Organisation 2019 Tuberculosis Infection Control Guidelines through the lens of a low-income/high TB burden country [2020]
• Malawi
  • Bulletin of the World Health Organization
    • Preventing tuberculosis among health workers in Malawi [2002]
• Mozambique
  • PLoS ONE
    • Healthcare Workers' Challenges in the Implementation of Tuberculosis Infection Prevention and Control Measures in Mozambique [2014]
• New Zealand
  • Ministry of Health New Zealand
    • 2012 Antigen Review for the New Zealand National Immunisation Schedule: Tuberculosis [2013]
• Republic of Korea
  • Clinical and Experimental Vaccine Research
    • BCG vaccine in Korea [2013]
• Saudi Arabia
  • International Journal of Infectious Diseases
    • Tuberculosis and mass gatherings—opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimage [2016]
  • Journal of Antivirals and Antiretrovirals
    • Bacillus Calmett-Guerin (BCG) Vaccination An Overview from Saudi Arabia [2016]
• South Africa
  • Cost Effectiveness and Resource Allocation
    • Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa [2014]
  • International Journal of Environmental Research and Public Health
    • Current Guidelines for Protecting Health Workers from Occupational Tuberculosis Are Necessary, but Not Sufficient: Towards a Comprehensive Occupational Health Approach [2020]
• South-East Asia
  • BMC Medicine
    • The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach [2020]
  • WHO Regional Office for South-East Asia
    • A situational analysis of programmatic management of TB preventive treatment in the WHO South-East Asia Region [2020]
• Sub-Saharan Africa
  • Bulletin of the World Health Organization
    • The role of the law in reducing tuberculosis transmission in Botswana, South Africa and Zambia [2016]
• United Kingdom
  • EuroSurveillance
    • Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015 [2019]
  • Health Technology Assessment
    • Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK [2017]
    • Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis [2013]
  • Public Health England
    • Intervax BCG vaccine: training material for healthcare professionals
  • Scottish Government
    • Health Clearance for Tuberculosis, Hepatitis B, Hepatitis C and HIV for New Healthcare Workers with Direct Clinical Contact with Patient [2008]
  • Thorax
    • The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection [2016]
• United States of America
  • Centers for Disease Control and Prevention
    • Tuberculosis - NIOSH Workplace Safety and Health Topic
    • TB | Infection Control
• WHO
  • World Health Organization
    • WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment [2020]
    • WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention: tuberculosis preventive treatment [2020]
    • WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment [2020]
    • Target product profiles for tuberculosis preventive treatment [2020]
    • Bacille Calmette-Guérin (BCG) vaccination and COVID-19 [2020]
    • WHO guidelines on tuberculosis infection prevention and control: 2019 update [2019]
    • WHO preferred product characteristics for new tuberculosis vaccines [2018]
    • Tuberculosis (BCG) vaccines: WHO position paper – February 2018 [2018]
    • Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria (NTM) infections [2017]
    • Tuberculosis prevention, care and control: a practical directory of new advances [2011]
    • The immunological basis for immunization series: module 5: tuberculosis - update 2011 [2011]
    • Report of a WHO consultation on strengthening the active engagement of civil society organizations in the global TB prevention, care and control efforts, September 30 - 1 October 2010, Geneva, Switzerland [2010]
    • Guidance on ethics of tuberculosis prevention, care and control [2010]
    • International collaborative study to evaluate and establish WHO reference reagents for BCG vaccine of three different substrains [2009]
    • Updated guidelines on tuberculosis and air travel [2008]
    • Tuberculosis and air travel. Guidelines for prevention and control [2008]
    • Guidelines for Workplace TB Control Activities [2003]
    • BCG - Immunization coverage estimates by country
• {Related topics}
  • Guidelines
    • Tuberculosis

Tuberculosis: screening, diagnosis

• Australia
  • Australian Family Physician
    • Tuberculosis testing [2012]
  • Department of Health Australia
    • Revised guidelines for Australian laboratories performing mycobacteriology testing [2018]
    • National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia [2017]
    • Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review [2015]
    • Guidelines for Australian Mycobacteriology Laboratories [2006]
  • Medical Services Advisory Committee
    • Pathology tests for active mycobacterial infection [2015]
• Belgium
  • Bulletin of the World Health Organization
    • Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium [2017]
• Botswana
  • American Journal of Respiratory and Critical Care Medicine
    • Costs and Consequences of Additional Chest X-Ray in a Tuberculosis Prevention Program in Botswana [2011]
• Brazil
  • Jornal Brasileiro de Pneumologia
    • Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System [2015]
    • Evaluation of the clinical utility of new diagnostic tests for tuberculosis: the role of pragmatic clinical trials [2012]
    • Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian meta-analysis [2008]
  • PLoS ONE
    • Market Assessment of Tuberculosis Diagnostics in Brazil in 2012 [2014]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Chest X-Rays Around Placement in Long-Term Care Facilities: A Review of Clinical Utility and Guidelines [2018]
    • Contact Investigations following Patient and Staff Exposure to Active Tuberculosis Infections: A Review of the Clinical Evidence and Guidelines [2014]
  • Frontiers in Public Health
    • Review of Evidence for Using Chest X-Rays for Active Tuberculosis Screening in Long-Term Care in Canada [2020]
  • Public Health Agency of Canada
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Tuberculosis surveillance and screening in selected high-risk populations [2014]
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Diagnosis of active tuberculosis and drug resistance [2014]
• China
  • BMC Medicine
    • Factors Associated with Patient, and Diagnostic Delays in Chinese TB Patients: A Systematic Review and Meta-analysis [2013]
  • Scientific Reports
    • Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review [2019]
• Côte d'Ivoire
  • PLoS ONE
    • Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities — Côte d’Ivoire [2016]
• Democratic Republic of Congo
  • Bulletin of the World Health Organization
    • Patient-led active tuberculosis case-finding in the Democratic Republic of the Congo [2018]
• Developing countries
  • Journal of Infection in Developing Countries
    • Cost-effectiveness in the diagnosis of tuberculosis: choices in developing countries [2014]
• Europe
  • European Centre for Disease Prevention and Control
    • Handbook on tuberculosis laboratory diagnostic methods in the European Union - Updated 2018 [2018]
    • Mastering the basics of TB control – Development of a handbook on TB diagnostic methods [2011]
  • EuroSurveillance
    • The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review [2018]
  • TBNET
    • Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe [2014]
    • Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis [2011]
  • WHO Regional Office for Europe
    • Tuberculosis Laboratory Maintenance Plan (LMP) for preventive and routine maintenance of laboratory equipment (2017) [2017]
• Germany
  • EuroSurveillance
    • Yield of active screening for tuberculosis among asylum seekers in Germany: a systematic review and meta-analysis [2017]
• India
  • Association of Physicians of India
    • Available Diagnostic Tools in Mycobacteriology: A Recap on Utility [2017]
  • BMC Medicine
    • Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model [2019]
  • BMJ Global Health
    • Initiative for Promoting Affordable and Quality Tuberculosis Tests (IPAQT): a market-shaping intervention in India [2019]
  • Indian Journal of Medical Research
    • Why India should become a global leader in high-quality, affordable TB diagnostics [2012]
    • Serological tests for the diagnosis of active tuberculosis: relevance for India [2012]
  • Indian Journal of Radiology & Imaging
    • Chest tuberculosis: Radiological review and imaging recommendations [2015]
• International
  • African Health Sciences
    • Effectiveness and costeffectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries [2014]
  • BMJ Open
    • ‘Power plays plus push’: experts’ insights into the development and implementation of active tuberculosis case-finding policies globally, a qualitative study [2020]
  • Bulletin of the World Health Organization
    • The impact of new tuberculosis diagnostics on transmission: why context matters [2012]
    • Can public-private collaboration promote tuberculosis case detection among the poor and vulnerable? [2006]
  • European Respiratory Journal
    • Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF [2013]
  • Gates Open Research
    • Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 [2018]
  • International Union Against Tuberculosis and Lung Disease
    • Laboratory Diagnosis of Tuberculosis by Sputum Microscopy: The Handbook [2013]
  • Journal of Infectious Diseases
    • Costs of Novel Tuberculosis Diagnostics—Will Countries Be Able to Afford It? [2015]
  • PLoS ONE
    • Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations [2014]
• Kenya
  • BMC Infectious Diseases
    • Variability in distribution and use of tuberculosis diagnostic tests in Kenya: a cross-sectional survey [2018]
• Low and middle-income countries
  • Clinical Microbiology Reviews
    • Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities [2011]
  • Journal of Infectious Diseases
    • Interferon-gamma Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysis [2011]
  • World Health Organization
    • Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries [2012]
    • Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries : policy statement [2011]
    • Use of interferon-y release assays (IGRAs) in tuberculosis control in low- and middle-income settngs: expert group meeting report 20-21 July 2010 [2011]
• Malawi
  • International Journal of Tuberculosis and Lung Disease
    • Impact of changing diagnostic criteria for smear-positive tuberculosis: a cohort study in Malawi [2014]
• Mozambique
  • Bulletin of the World Health Organization
    • Implementing rapid testing for tuberculosis in Mozambique [2015]
• New Zealand
  • Ministry of Health New Zealand
    • Technical Guidelines for Tuberculin Skin Test [2018]
• Norway
  • EuroSurveillance
    • Targeting TB or MRSA in Norwegian municipalities during ‘the refugee crisis’ of 2015: a framework for priority setting in screening [2019]
• Republic of Korea
  • Tuberculosis and Respiratory Diseases
    • Diagnosis of Pulmonary Tuberculosis: Recent Advances and Diagnostic Algorithms [2015]
    • Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea [2014]
• Russia
  • PLoS Medicine
    • Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis [2012]
• South Africa
  • BMC Medicine
    • How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India [2014]
  • Journal of Clinical Microbiology
    • Diagnostic Accuracy of Xpert MTB/RIF for Extrapulmonary Tuberculosis Specimens: Establishing a Laboratory Testing Algorithm for South Africa [2014]
  • Journal of Infectious Diseases
    • Against All Odds: Diagnosing Tuberculosis in South Africa [2011]
  • PLoS ONE
    • The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa [2012]
• Spain
  • Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
    • Guidelines for the use of interferon-gamma release assays in the diagnosis of tuberculosis infection [2016]
• Sub-Saharan Africa
  • Annals of African Medicine
    • Advances in the laboratory diagnosis of Mycobacterium tuberculosis [2008]
• Taiwan
  • Journal of the Formosan Medical Association
    • Early diagnosis of spinal tuberculosis [2016]
• Tanzania
  • Ministry of Health, Community Development, Gender, Elderly and Children
    • Quality improvement for TB case detection [2017]
• Tonga
  • Public Health Action
    • Sputum smear microscopy referral rates and turnaround time in the Tonga Islands [2014]
• Uganda
  • BMC Health Services Research
    • Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions [2015]
  • Centers for Disease Control and Prevention
    • Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015 [2017]
  • PLoS ONE
    • Theory-Informed Interventions to Improve the Quality of Tuberculosis Evaluation at Ugandan Health Centers: A Quasi-Experimental Study [2015]
• United Kingdom
  • Health Technology Assessment
    • Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation [2019]
    • Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study [2018]
  • Public Health England
    • Tuberculosis: pre-entry screening in the UK
    • Tuberculosis screening
    • Tuberculosis (TB): molecular diagnosis
    • Tuberculosis (TB) in the workplace
    • SMI B 40: Investigation of specimens for Mycobacterium species
    • National mycobacterium reference laboratory: user manual
• United States of America
  • American College of Radiology
    • Imaging of Possible Tuberculosis
  • American Thoracic Society
    • Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children [2017]
  • Centers for Disease Control and Prevention
    • Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice [2019]
    • Implementation of New TB Screening Requirements for U.S.-Bound Immigrants and Refugees — 2007–2014 [2014]
    • Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection --- United States, 2010 [2010]
    • TB | Testing & Diagnosis
    • Laboratory Information | TB
  • PLoS ONE
    • Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review [2019]
• Vietnam
  • BMC Public Health
    • A household survey on screening practices of household contacts of smear positive tuberculosis patients in Vietnam [2014]
• WHO
  • World Health Organization
    • WHO operational handbook on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection [2020]
    • WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection [2020]
    • Rapid communication on the systematic screening for tuberculosis [2020]
    • Framework for the evaluation of new tests for tuberculosis infection [2020]
    • Technical expert group meeting report: commercial products for preserving clinical specimens for the diagnosis of tuberculosis [2017]
    • Consensus meeting report: development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease [2017]
    • The Use of Loop-Mediated Isothermal Amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance [2016]
    • Framework of indicators and targets for laboratory strengthening under the End TB Strategy [2016]
    • Chest radiography in tuberculosis detection: Summary of current WHO recommendations and guidance on programmatic approaches [2016]
    • Systematic screening for active tuberculosis: an operational guide [2015]
    • Operational guidance on systematic screening for active tuberculosis [2015]
    • Implementing tuberculosis diagnostics: A policy framework [2015]
    • High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting [2014]
    • Systematic screening for active tuberculosis: principles and recommendations [2013]
    • Tuberculosis Laboratory Biosafety Manual [2012]
    • Same-day diagnosis of tuberculosis: policy statement [2011]
    • Guidance for countries on the specifications for managing TB laboratory equipment and supplies [2011]
    • Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis: policy statement [2011]
    • Early detection of Tuberculosis. An overview of approaches, guidelines and tools [2011]
    • Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement [2011]
    • Commercial serodiagnostic tests for diagnosis of tuberculosis: expert group meeting report 22 July 2010 [2011]
    • Publications on TB detection and diagnosis
• {Related topics}
  • Guidelines
    • Tuberculosis

Tuberculosis: treatment

• Armenia
  • Interdisciplinary Perspectives on Infectious Diseases
    • Reasons for Delay in Seeking Care for Tuberculosis, Republic of Armenia, 2006–2007 [2010]
• Australia
  • Queensland Clinical Guidelines
    • Treatment of Tuberculosis in Adults and Children [2015]
• Brazil
  • BMC Health Services Research
    • Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services [2016]
  • BMC Public Health
    • Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in Brazil: an ecological study [2013]
  • Jornal Brasileiro de Pneumologia
    • Evaluation of the impact that the changes in tuberculosis treatment implemented in Brazil in 2009 have had on disease control in the country [2017]
    • Antituberculosis drugs: drug interactions, adverse effects, and use in special situations - part 2: second line drugs [2010]
    • Antituberculosis drugs: drug interactions, adverse effects, and use in special situations - part 1: first-line drugs [2010]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Portable or Temporary Negative Pressure Rooms for Tuberculosis: Clinical Effectiveness and Guidelines [2020]
    • Management of Discontinued Treatment for Tuberculosis: Guidelines [2020]
  • Public Health Agency of Canada
    • Canadian Tuberculosis Standards 7th Edition: 2014 – Treatment of Tuberculosis disease [2014]
• China
  • BMC Public Health
    • Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review [2011]
  • Infectious Diseases of Poverty
    • Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study [2016]
    • The production and sales of anti-tuberculosis drugs in China [2016]
    • Implementing a “free” tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world [2016]
• Colombia
  • Revista Española de Quimioterapia
    • Antimycobacterial natural products--an opportunity for the Colombian biodiversity [2011]
• Denmark
  • BMC Health Services Research
    • Review of tuberculosis treatment outcome reporting system in Denmark, a retrospective study cohort study from 2009 through 2014 [2020]
  • Scientific Reports
    • Predictors for Pulmonary Tuberculosis Treatment Outcome in Denmark 2009–2014 [2019]
• Dominican Republic
  • Revista Panamericana de Salud Pública
    • Tuberculosis patients in the Dominican Republic face severe direct and indirect costs and need social protection [2013]
• Ethiopia
  • Bulletin of the World Health Organization
    • Untreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia [2018]
• Europe
  • European Centre for Disease Prevention and Control
    • Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA [2015]
  • European Respiratory Journal
    • Tuberculosis treatment outcome monitoring in European Union countries: systematic review [2013]
  • EuroSurveillance
    • Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011 [2015]
• Finland
  • BMC Public Health
    • Risk factors affecting treatment outcomes for pulmonary tuberculosis in Finland 2007–2014: a national cohort study [2020]
• France
  • EuroSurveillance
    • Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014 [2020]
• Georgia
  • Bulletin of the World Health Organization
    • Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience [2012]
• Germany
  • ERJ Open Research
    • Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update [2020]
  • EuroSurveillance
    • Find and treat or find and lose? Tuberculosis treatment outcomes among screened newly arrived asylum seekers in Germany 2002 to 2014 [2018]
• Ghana
  • International Journal of Mycobacteriology
    • Medicinal plants used to treat TB in Ghana [2015]
• India
  • Lancet Infectious Diseases
    • The number of privately treated tuberculosis cases in India: an estimation from drug sales data [2016]
  • Lung India
    • DOTS for TB relapse in India: A systematic review [2012]
  • PLoS ONE
    • A model-based investigation into urban-rural disparities in tuberculosis treatment outcomes under the Revised National Tuberculosis Control Programme in India [2020]
    • Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines? [2012]
  • Public Health Action
    • How much do Indians pay for tuberculosis treatment? A cost analysis [2020]
• International
  • Bulletin of the World Health Organization
    • The Global Drug Facility as an intervention in the market for tuberculosis drugs [2015]
    • Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone [2014]
    • Treatment of tuberculosis: present status and future prospects [2005]
  • PLoS Medicine
    • Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam [2019]
  • Treatment Action Group
    • An Activist’s Guide to Regulatory Issues: Ensuring Fair Evaluation of and Access to Tuberculosis Treatment [2015]
  • U.S. Agency for International Development
    • Summary Table of TB Treatment Regimens [2017]
• Kenya
  • Health and Human Rights Journal
    • Detention of People Lost to Follow-Up on TB Treatment in Kenya [2016]
  • PLoS ONE
    • Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya [2016]
• Latvia
  • Public Health Action
    • Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006–2010 [2014]
• Low and middle-income countries
  • Bulletin of the World Health Organization
    • Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis [2018]
  • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    • Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities [2019]
• Malaysia
  • PLoS ONE
    • Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study [2020]
• Moldova
  • Public Health Action
    • Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? [2014]
• Mozambique
  • BMC Infectious Diseases
    • Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012) [2016]
• Nigeria
  • World Journal of Methodology
    • Profile and determinants of unsuccessful tuberculosis outcome in rural Nigeria: Implications for tuberculosis control [2016]
• Pakistan
  • Journal of Pakistan Medical Association
    • Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury [2014]
• Republic of Korea
  • Annals of Laboratory Medicine
    • Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations [2017]
• South Africa
  • Health and Quality of Life Outcomes
    • Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis– a systematic review of global literature with focus on South Africa [2016]
  • PLoS ONE
    • The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa [2015]
  • South African Medical Journal
    • Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa [2014]
• Spain
  • Archivos de Bronconeumología
    • Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment [2016]
• Sub-Saharan Africa
  • African Health Sciences
    • A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa [2010]
  • Global Health Action
    • Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth [2017]
  • Patient preference and adherence
    • An ontology for factors affecting tuberculosis treatment adherence behavior in sub-Saharan Africa [2016]
  • Pharmacogenomics
    • Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study [2015]
• Taiwan
  • PLoS ONE
    • Improved Consistency in Dosing Anti-Tuberculosis Drugs in Taipei, Taiwan [2012]
• Turkey
  • Tuberculosis and Thorax
    • Treatment of tuberculosis in Turkey in terms of medical ethics [2015]
• Uganda
  • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
    • Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda [2020]
• United States of America
  • American Thoracic Society
    • Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis [2016]
    • An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy [2006]
  • Centers for Disease Control and Prevention
    • Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection [2011]
    • TB | Treatment
  • Clinical Gastroenterology and Hepatology
    • Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity [2015]
  • Society of Infectious Diseases Pharmacists
    • Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists [2009]
• Uzbekistan
  • Health Economics Review
    • Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan [2016]
  • PLoS ONE
    • Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study [2015]
• WHO
  • World Health Organization
    • Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis [2018]
    • Report of the technical consultation on advances in clinical trial design for development of new TB treatments: Glion-sur-Montreux, Switzerland, 14-16 March 2018 [2018]
    • Handbook for the use of digital technologies to support tuberculosis medication adherence [2017]
    • Guidelines for treatment of drug-susceptible tuberculosis and patient care [2017]
    • Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis [2017]
    • Target Regimen Profiles for TB Treatment [2016]
    • Active tuberculosis drug-safety monitoring and management (aDSM): Framework for implementation [2015]
    • Policy Implementation Package for new TB drug introduction [2014]
    • A Practical Handbook on the Pharmacovigilance of Medicines Used in the Treatment of Tuberculosis: Enhancing the Safety of the TB Patient [2012]
    • Guidelines for treatment of tuberculosis, fourth edition [2010]
    • Green Light Committee application instructions [2010]
    • WHO policy on TB infection control in health-care facilities, congregate settings and households [2009]
    • Assessment of human resources and time needed to implement the DOTS strategy for TB control in health facilities : survey instrument and guide to implementation [2008]
    • Treatment success - Data by country
• {Related topics}
  • Guidelines
    • Tuberculosis: drug resistance
    • Tuberculosis